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ABSTRACT
Direct recruitment of eIF4GI and/DAP5 to the 5' UTR of a subset of human mRNA drives their
cap-independent translation
By
Solomon Haizel
Advisor: Professor Dixie J. Goss
During unfavorable cellular conditions (e.g., tumor hypoxia, viral infection, nutrient deprivation,
etc.), the canonical, cap-dependent translation initiation pathway in human cells is suppressed by
sequestration of the cap-binding protein, eukaryotic initiation factor(eIF) 4E, by 4E-binding
proteins.

Circumvention of cap-dependent translation shutdown has been linked to tumor

development and cancer progression. The stress-induced repression of cap-dependent translation
has also been correlated with increased eIF4GI and its homolog, Death Associated Protein 5
(DAP5) expression levels, suggesting these factors have a role in cap-independent translation.
Despite several evidence pointing towards a link upregulation of eIF4GI and /DAP5 levels during
stress conditions, and the cap-independent translation of a subset of stress response mRNAs (e.g.
HIF-1α, FGF-9, and p53) that drives cancer and tumor development, there has been reports
showing direct quantitative measurement of these mRNAs (containing structured 5’ UTR) binding
to eIF4GI/DAP5 and whether this binding drives their cap-independent translation in an
eIF4GI/DAP5-dependent manner. Further, the mechanistic underpinnings of how these RNA
structures within the 5’ UTRs recruits eIF4GI and/DAP5 to bypass 4EBP-mediated sequestration
of eIF4E and switch from cap-dependent to cap-independent translation initiation mechanism is
not well understood. Also, there are no reports showing the role of additional initiation factors in
these translation mechanisms.
iv

The work described in this dissertation address this gap in knowledge by using fluorescence
anisotropy-based equilibrium binding assay and luciferase-based gene expression reporter assay
to provide new insights into how a subsets of human mRNAs with structured 5’ UTRs (HIF-1α,
FGF-9, p53A and p53B ) recruits either eIF4GI or DAP5 to mediate cap-independent mRNA
translation. Results from this study provide evidence that these 5’ UTRs bind with different
affinities to these proteins and that these same 5’ UTRs can promote cap-independent initiation in
an eIF4GI or DAP5-dependent manner in a rabbit reticulocyte lysate depleted of eIF4GI or DAP5.
We also show how translation of this subset of mRNAs with structured 5’ UTRs are either
dependent on the availability of an exposed 5’ end or not, allowing us to distinguish between IRESor CITE-mediated modes of cap-independent translation among this subset of cellular mRNAs.
Further studies showed these mRNAs had distinct preferences for the additional initiation factors
(eIF4A, eIF4B and eIF4E) required by these mRNAs for their cap-independent translation
initiation, adding to our understanding of these different cap-independent translation mechanisms.
Collectively, the quantitative binding- and in vitro translation studies obtained from this work
allowed us to propose a model showing how eIF4GI/DAP5, and/or additional initiation factors are
directly recruited to the structured 5’ UTRs of this subset of cellular mRNAs to facilitate a switch
from cap-dependent to cap-independent modes of translation initiation.

v

ACKNOWLEDGEMENTS
I would like to express my profound gratitude to my mentor Prof. Dixie J. Goss for
providing me the opportunity to work in her laboratory, providing me with all the support and
advice. You encouraged me to develop my own scientific ideas and provided me the oppootunity
to be part of the scientific community by allowing me to attend scientific conferences and
workshops that propelled me to grow professionally and become the scientist that I am today.
Thank you for your guidance and mentorship throughout the duration of my doctoral studies. I am
grateful to have a more supportive and understanding advisor.
I am grateful to my co-advisor, Prof. Ruben L Gonzalez Jr. for maintaining collaboration
with us on this project. Working in collaboration with you on this project have sharpen my thinking,
accelerated my professional development and taught me to be a very critical scientist. I am thankful
for your technical and critical comments on my manuscript. Thank you for providing me the
platform to present my work to the scientific community in Columbia University. I could not have
wished for a better co-advisor.
Further, I am grateful to Dr. Somdeb Mitra for helping me get started with my project and
sharing his extensive knowledge with me. Thank you for your comments on the manuscript,
supports and contributions to the project.
I would like to thank my thesis advisory committee members, Prof. Kevin Gardner, Prof.
Frida Kleiman, late Prof. Charles Drain and Prof. Akira Kawamura for their insightful and
invaluable suggestions.
Furthermore, I am grateful to the Graduate Center of the City University of New York for
accepting me into the Ph.D. program in Biochemistry and awarding me with the CUNY Science

vi

Scholarship for financial support. This allowed me to focus on research and thanks to them, I will
be graduating with my Ph.D in biochemistry honours.
I also would like to thank my colleagues at the Goss Lab in Hunter college for all their
support throughout my studies. Dr. Usha Bhardwaj, for insightful and productive discussions on
this project, for training me on protein purification and significant contribution to the manuscript.
Paul Powell for advice and interesting discussion on Kintek stop flow titration model, throughout
my Ph D. studies. I would like to thank other members of Goss Lab for helpful discussions, Dr.
Baishakki Saha, Budimir Zdravkovic, Jacob Quartey, Amanda Whittaker, and Inayah Entzminger.
Moreover, I am grateful to friends who made my transition to hitherto foreign place
relatively easy and fun. Grateful for Pierpaolo Condone, who was the first colleague I interacted
with, very enthusiastic and happy we share a common fun for soccer. Alison Domzalski, for
showing me around NYC. Devon Semoy, who in many ways has become like a brother to me. I
admire your work ethic, discussion on various issues, positive attitude to life and introducing me
to almost all your family members. I totally enjoy thanksgiving and Christmas meals. Also
essential to my success are great friends like George Annor and David Dansu who has been a rock
of support and encouragement.
Finally, I owe my family a big thank you for all their support and sacrifices. I am extremely
indebted to my parents who overcame incredible challenges to allow me to choose my own path.
They provided me the opportunity and financial support to achieve my dream and encouraged me
in every step of the way especially during my difficult period in my Ph.D journey.

vii

Table of Contents
Title page ......................................................................................................................................... i
Copyright page................................................................................................................................ ii
Approval page ................................................................................................................................ iii
Abstract .......................................................................................................................................... iv
Acknowledgements ......................................................................................................................... vi
List of Tables ................................................................................................................................ xiii
List of Figures ............................................................................................................................... xiv
Introduction..................................................................................................................................... 1
CHAPTER 1 .................................................................................................................................... 2
1.1 Overview of Cap-Dependent Translation Mechanism ......................................................... 2
1.2. eIF4F Complex Mediates Cap-dependent Initiation ........................................................... 6
1.2.1 Eukaryotic cells Express Multiple eIF4G-like Proteins..................................................... 6
1.2.2 DAP5 mediates Translation of Subset of mRNAs ............................................................. 8
1.3. Cap-Independent Translation Initiation Mechanisms .......................................................... 9
1.3.1. IRES-mediated Cap-Independent Translation Initiation Mechanism ......................... 11
1.3.2. CITE-mediated Cap-Independent Translation Initiation Mechanism......................... 12
Figure 1.3.2. Mechanisms of cap-independent translation initiations ......................................... 14
1.3.3 Other Cap-independent Translation Mechanisms ........................................................ 14
Figure 1.3.3. Non-canonical translation initiation mechanisms .................................................. 15
viii

1.4. Some EIFs Implicated In Cap-Independent Translation Initiation .................................... 16
1.4.1. Eukaryotic Initiation Factors 4GI (eIF4GI) and 4EBP1 ................................................. 16
1.4.2. Death-Associated Protein 5 (DAP5) ............................................................................... 16
1.5. Purpose and Specific Aims of Proposed Study ...................................................................... 18
1.5.1. Hypothesis and Specific Aims .................................................................................... 19
1.5.1a. Specific Aim 1: ......................................................................................................... 19
1.5.1b. Specific Aim 2: ......................................................................................................... 20
1.5.1c. Specific Aim 3: ......................................................................................................... 20
CHAPTER 2 .................................................................................................................................. 22
5’ UTR RECRUITMENT OF eIF4GI OR DAP5 DRIVES CAP-INDEPENDENT TRANSLATION
FOR A SUBSET OF HUMAN mRNAS ......................................................................................... 22
2.1 Abstract ................................................................................................................................... 23
2.2 Introduction............................................................................................................................. 24
2.3 Results ..................................................................................................................................... 28
2.3.1 eIF4GI and DAP5 bind specifically and with differential affinities to the 5’ UTRs of a
subset of cellular mRNAs ......................................................................................................... 28
2.3.2 The binding of eIF4GI and DAP5 is specific to the 5’ UTRs of the selected mRNAs ... 29
2.3.3 The 5’ UTRs of a subset of cellular mRNAs that bind eIF4GI and DAP5 can drive capindependent translation ............................................................................................................. 31
2.2.4 eIF4GI and DAP5 stimulate and restore cap-independent in vitro translation of the selected
5’ UTR-Luc mRNAs................................................................................................................. 32
ix

2.2.5 An exposed 5’ end is important for the cap-independent translation activities of HIF-1α
and p53A UTR-Luc mRNAs, but not FGF-9 and p53B UTR-Luc mRNAs .............................. 34
2.3 Discussion ............................................................................................................................... 35
2.4 Experimental procedures ........................................................................................................ 39
2.4.1 Preparation of RNAs for fluorescence anisotropy-based equilibrium binding studies.... 39
2.4.2 Preparation of eIF4GI557-1599, eIF4GI682-1599, and DAP5 ................................................. 40
2.4.3 Fluorescence anisotropy-based equilibrium binding assays ............................................ 41
2.4.4 Preparation of UTR-Luc reporter mRNAs for luciferase-based gene expression reporter
assays ........................................................................................................................................ 42
2.4.5 Western Blots and depletion of eIF4GI and DAP5 from the rabbit reticulocyte lysate .. 44
2.4.6 Luciferase-based gene expression reporter assays ........................................................... 45
2.4.7 Data availability ............................................................................................................... 46
2.5 Acknowledgments .................................................................................................................... 46
2.6 Conflict of interest statement .................................................................................................. 47
2.8 Figures and legends ................................................................................................................ 50
2.9 Supplementary data ................................................................................................................ 60
CHAPTER 3 .................................................................................................................................. 65
Investigating the roles of additional eukaryotic initiation factors in the recruitment of eIF4GI to
the untranslated region (UTR) of a subset of human mRNAs....................................................... 65

x

Dissecting the roles of eIF4A, eIF4B and eIF4E in the recruitment of eukaryotic initiation factor
4GI (eIF4GI) to the untranslated region (UTR) of a subset of human mRNAs ............................ 65
3.1 Abstract ................................................................................................................................... 66
3.2 Introduction............................................................................................................................. 66
3.3 Results ..................................................................................................................................... 68
3.3.1 Other eukaryotic initiation factors (eIFs) bind with different affinities to the 5’ UTRs of
FGF-9 and HIF-1α .................................................................................................................... 68
3.3.2 eIF4A and eIF4E enhance the binding affinity of eIF4GI557-1599 to the 5’ UTR of HIF-1α
mRNAs but not FGF-9 ............................................................................................................. 69
3.3.4 ATP hydrolysis may not be important for efficient recruitment of eIF4GI to the 5’ UTRs
of FGF-9 and HIF-1α ................................................................................................................ 70
3.4 Discussion ............................................................................................................................... 72
3.5 Experimental procedures ........................................................................................................ 75
3.5.2 Purification of Proteins .................................................................................................... 76
3.5.3 Fluorescence anisotropy-based equilibrium binding assays ............................................ 77
3.5.4 Determinations of Number of Binding Sites ................................................................... 78
3.5.5 Preparation of UTR-Luc reporter mRNAs for luciferase-based gene expression reporter
assays ........................................................................................................................................ 79
3.5.6 Luciferase-based gene expression reporter assays ........................................................... 80
3.5.7 Data availability ............................................................................................................... 81

xi

All data are present in the manuscript.......................................................................................... 81
Figures and Legends ..................................................................................................................... 83
Supplementary Data...................................................................................................................... 94
CHAPTER 4 ................................................................................................................................ 102
4.1 Conclusion and Future directions ........................................................................................ 102
4.2

Conclusion .................................................................................................................. 102

4.3 Future Direction ................................................................................................................ 105
Bibliography ............................................................................................................................... 109
CONFERENCES/WORKSHOPS ................................................................................................ 124

xii

LIST OF TABLES
Chapter 2
Table 2.1. Parameters describing the equilibrium binding of eIF4GI constructs and DAP5 to the
5’ UTRs ......................................................................................................................................... 48
Table 2.2. Primers used for the cloning of the UTRs in reporter constructs ............................... 49
Table S2.1. Parameters describing the equilibrium binding of eIF4GI mutants and DAP5 to 5’
UTRs ............................................................................................................................................. 49

Chapter 3
Table 3.1. Parameters describing the equilibrium binding of proteins to the 5’ UTR of FGF-9. 82
Table 3.2. Parameters describing the equilibrium binding of proteins to the 5’ UTR of HIF-1α 82

xiii

LIST OF FIGURES
Chapter 1
Figure 1.1a. Cartoon describing the steps in cap-dependent translation mechanisms .................. 4
Figure 1.1b. Cartoon describing A. Elongation and B. Termination steps of protein synthesis .... 5
Figure 1.2. Schematic representation of the domain architecture showing conparisons of eIF4GI,
eIF4GII and DAP5 across different eukaryotic species ................................................................. 7
Figure 1.3. Pathway describing the canonical cap-dependent and nono-canical cap-independent
translation initiation mechanisms ................................................................................................. 10
Figure 1.3.1. Purported models for mechanisms of IRES-mediated translation initiation in viral
systems .......................................................................................................................................... 12

Chapter 2
Figure 2.1. Domain structure and sequence alignment between eIF4GI and DAP5 .................. 50
Figure 2.2. Equilibrium binding-titrations of 5’ UTRs with eIF4GI557-1599, eIF4GI682-1599, and
DAP5. ............................................................................................................................................ 51
Figure 2.3. Equilibrium binding titrations of fluorescein labeled ferritin IRE, EMCV J/K IRES , bactin UTR and polyUC................................................................................................................. 53
Figure 2.4. Effect of eIF4GI557-1599, eIF4GI682-1599, and DAP5 on the expression of ApppG cappedUTR-Luc mRNAs........................................................................................................................... 56
Figure 2.5. Effect of a stable 5’ hairpin (hp) inserted at the 5’ terminal of UTR-Luc mRNAs. ... 57

xiv

Figure 2.6. Cartoon summarizing models for canonical (cap-dependent) and the proposed
cap/eIF4E independent translation initiation ............................................................................... 58
Supplementary Figure. 2.1. Comparison of cap-dependent and cap-independent translation
activities ........................................................................................................................................ 61
Supplementary Figure. 2.2. Effect of 4EGI-1 on the translation yields of UTR-Luc mRNAs ...... 62
Supplementary Figure. 2.3. Depletion of eIF4GI or DAP5 have little effect on eIF4E, eIF2β, and
eIF4AI levels ................................................................................................................................. 63
Supplementary Figure 2.4. Effect of eIF4GI mutants and DAP5 on the expression of m7GpppAcapped β-act-UTR-Luc mRNA ...................................................................................................... 64

Chapter 3
Figure 3.1. Equilibrium binding-titrations of 5’ UTRs of FGF-9 and HIF-1α with eIF4GI557-1599,
eIF4B, eIF4E and eIF4A............................................................................................................... 83
Figure 3.2. Equilibrium binding-titrations of 5’ UTRs of FGF-9 and HIF-1α with saturating
amount of eIF4A and eIF4GI557-1599. ............................................................................................ 85
Figure 3.3. Equilibrium binding titrations of fluorescein labeled FGF-9 and HIF-1α binding to
eIF4GI557-1599 and a saturating amount of eIF4E and eIF4GI557-1599 ........................................... 86
Figure 3.4. Equilibrium binding titrations of fluorescein labeled FGF-9 and HIF-1α binding to
the helicase complex ..................................................................................................................... 88
Figure 3.5. Rocaglamide and 4EGI-1 differentially affect the cap-independent activities of FGF9-UTR-Luc and HIF-1α-UTR-Luc reporters ................................................................................ 90
xv

Figure 3.6 Effect of eIF4A and eIF4E on the cap-independent activities of FGF-9 and HIF-1αUTR-Luc reporters ........................................................................................................................ 91
Figure 3.7. Cartoon summarizing models of cap-independent translation switch under stress
condition. ...................................................................................................................................... 92
Figure 3.1. Equilibrium binding-titrations of 5’ UTRs with eIF4GI557-1599, eIF4B, eIF4E and
eIF4A............................................................................................................................................. 83
Figure 3.2. Equilibrium binding-titrations of 5’ UTRs of FGF-9 and HIF-1α with saturating
amount of eIF4A and eIF4GI557-1599. ............................................................................................ 85
Figure 3.3. Equilibrium binding titrations of fluorescein labeled FGF-9 and HIF-1α binding to
eIF4GI557-1599 and a saturating amount of eIF4E and eIF4GI557-1599 ........................................... 86
Figure 3.4. Equilibrium binding titrations of fluorescein labeled FGF-9 and HIF-1α binding to
the helicase complex ..................................................................................................................... 88
Figure 3.5. Rocaglamide and 4EGI-1 differentially affect the cap-independent activities of FGF9-UTR-Luc and HIF-1α-UTR-Luc reporters. A. Cartoon representation of the mRNA reporter
used for this study. Translation yields of B. FGF-9-UTR-Luc mRNA and C. HIF-1α-UTR-mRNA
were monitored in nuclease-treated RRL supplemented with DMSO (control) or increasing
concentrations of........................................................................................................................... 90
Figure 3.6 Effect of eIF4A and eIF4E on the cap-independent activities of FGF-9 and HIF-1αUTR-Luc reporters. Translation yields of A. ApppG-capped-FGF-9-UTR-Luc mRNA and B.
ApppG-capped- HIF-1α-UTR-Luc mRNA following treatment of the RRL with 60 nM of
Rocaglamide (RRL(+)RocA) and increasing concentration of eIF4A. C. Translation yields of ApppGcapped-HIF-1α-UTR-Luc mRNA following treatment of the RRL with 60 .................................. 91
xvi

Figure 3.7. Cartoon summarizing models of cap-independent translation switch under stress
condition.
92
Figure S1. Equilibrium binding-titrations of unstructured polyUC with eIF4GI557-1599, eIF4B,
eIF4E and eIF4A........................................................................................................................... 94
Figure S2. Equilibrium binding-titrations of flourecein labelled 5’ UTR of A. FGF-9 and B. HIF1α with eIF4GI557-1599 eIF4E and eIF4A mixture (eIF4GI+4A+4E) ................................................. 95
Figure S3. Predicted secondary structures for A. HIF-1α and B. FGF-9 using RNA2Drawer .. 96
Figure S4. Domain architecture of eIF4GI557-1599 used for this study .......................................... 97
Figure S5. Modified Stern−Volmer plots showing the fluorescence quenching .......................... 99
Figure S6. Modified Stern−Volmer plots showing the fluorescence quenching

101

Chapter 4
Figure 4.1 Predicted Y-shape motif common among the 5’ UTR of HIF-1α, FGF-9 , p53A and
p53B using RNAalifold software................................................................................................ 106
Figure 4.2 Predicted secondary structures and alignments ....................................................... 107

xvii

LIST OF ABBREVIATIONS
5’ UTR – 5’ Untranslated Region
eIF – eukaryotic Initiation Fator
eRF – eukaryotic Release Factor
DAP5 – Death Associated Protein 5
CITE – Cap-Independepent Translation Elements
IRES – Internal Ribosome Entry Site
mRNA – messenger RNA
m7G – 7-methylguanosine
ApppG – P1-(5’-Adenosyl) P3-(5’ guanosyl) triphosphate
4E-GI-1– eIF4E/eIF4G Interaction Inhibitor 1
Fluc – Firefly Luciferase
ATP – Adenosine Triphosphate
GTP – Guanosine Triphosphate
GDP – Gunosine diphosphate
PABP – PolyA-Binding Protein
4E-BD – eIF4E-Binding Domain
VEGF – Vascular Endothelial Growth Factor
HIF-1α –Hypoxia Inducible Factor 1-alpha
p53 – Tumor protein 53
FGF-9 – Fibrobast Growth Factor 9
EMCV –Encephalomyocarditis Virus

xviii

1. INTRODUCTION
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CHAPTER 1
1.1 Overview of Cap-Dependent Translation Mechanism
Translation of mRNAs into proteins in eukaryotes is a highly regulated process in cells that is
categorized into four cyclical key steps namely, initiation, elongation, termination, and ribosome
recycling (Fig. 1.1a) (1,2).
The initiation of protein synthesis begins with the recognition and binding of the eIF4F
complex (eIF4G, eIF4E and eIF4A) at 5’ terminal 7-methylguanosine (m7Gp) cap of mRNA,
recruitment of the 43S pre-initiation complex (PIC) which consists of the small 40S ribosomal
subunit, eIF3, eIF1, eIF1A, eIF5, eIF2, GTP and Met-tRNAi small ribosomal subunit and
subsequent scanning of the 5’ Untranslated Region (UTR) by helicase factors (eIF4A, eIF4B and
ATP) to the AUG start codon (1,3). The recruitment of the 43S PIC is facilitated by the
circularization of the mRNAs mediated by the interaction between the eIF4G scaffold protein at
the 5’ end of the mRNA and the poly A binding protein (PABP) at the 3’ end of the mRNA (4).
Another eukaryotic initiation factor (eIF), eIF3, interacts with eIF4G to bring the 40S ribosome to
the mRNA (5). Scanning of the 5’UTR in a 5’-to-3’ direction continues until an AUG start codon
in the correct Kozak context (RCCAUGG, where R is any purine) is met (6). Upon start codon
recognition, the methionylated initiator tRNA (Met-tRNAi Met) base-pairs with the codon in the
ribosomal P-site to form the 48S initiation complex (IC) and subsequent hydrolysis of eIF2-bound
GTP and inorganic phosphate release (Pi) (1). Attachment of the large 60S ribosomal subunit to
the 48S IC mediated by eIF5B and release of eIF2-GDP and other eIFs (eIF1, eIF3, eIF4B,
eIF4Fand eIF5) lead to the formation of an elongation-competent 80S ribosomal IC (1).
The elongation step of protein synthesis is divided into 3 steps namely: activation of the
amino acids, peptide bond formation and translocation (7). The aminoacyl-tRNA enters the A-site
2

of the ribosome and using its base triplets (anticodon), base-pair with the codons on the mRNA.
The anticodon-codon interaction is facilitated by the elongation factor, eEF1A which hydrolyzes
GTP to provide energy needed to activate the aminoacyl-tRNAs and eEF1B which ensure
continuous exchange and conversion of eEF1A.GDP to eEF1A.GTP for the next round of
aminoacyl-tRNA activation (Fig. 1.1b). Following peptide bond formation with the peptidyl-tRNA,
the peptide is now translocated to the P-site aided by GTP hydrolysis by eEF2. The deacylated
tRNA is then shifted to the E-site of the ribosome and the A site is now vacant for the incoming
activated amino acid and next round of elongation (Fig. 1.1b) (7).
Termination of translation occurs when the ribosome encounters a stop codon (UAA, UGA,
or UAG) at its A-site triggering disassembly of the ribosomal subunits. This reaction is catalyzed
by release factors eRF1 and eRF3 (8,9) which recognize the stop codon on the mRNA and release
the polypeptide, respectively. Correct sensing and recognition of the stop codon by eRF1 is aided
by ABCE1/Rli1 and release of the polypeptide requires GTP hydrolysis by eRF3 (Fig. 1.1b) (7).
The final step of protein synthesis is the dissociation of the 80S ribosome, deacylated tRNA
and mRNA from the synthesized polypeptide allowing for the recycling of the ribosomal subunits
to facilitate the next round of translation or reinitiation of translation (7).

3

Figure 1.1a. Cartoon describing the steps in cap-dependent translation mechanisms. The 4 main
steps of translation namely; initiation, elongation, termination and ribosome recycling are shown.
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The figure was extracted with permission from Ali et al., Tumour Biol, 2017, 39, 1-19. Copyright
(2017), SAGE Publications.

B.

Figure 1.1b. Cartoon describing A. Elongation and B. Termination steps of protein synthesis.
The figures were extracted with permission from T.E. Denver and R. Green, Cold Spring Harb
Perspect Biol, 2012, 4(7): a013706. Copyright (2012), Cold Spring Harbor Laboratory Press.
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1.2. eIF4F Complex Mediates Cap-dependent Initiation
Protein synthesis can use up to 80% of the cell’s energy and thus it is highly regulated at
the initiation step (3,10). Thus, when nutrients are scarce or the cell is under stress conditions,
protein synthesis can be completely shutdown (11). The availability, correct assembly and binding
of the eIF4F complex at the 5’ end of mRNA affect the rate of translation initiation (2). The
assembly of the eIF4F complex is under the regulation of key signaling pathways that controls the
phosphorylation status and activity of 4E-Binding Protein (4EBP1) and eIF4E (12,13). 4EBP1
shares a common consensus binding motif with eIF4GI (14) on eIF4E and under normal
physiological conditions, when 4EBP1 is hyper phosphorylated by the mammalian target of
rapamycin (mTOR complex) leading to its inactivation, eIF4GI mediates interaction with eIF4E
and eIF4A, and allows recruitment of the translationally active eIF4F complex to the m7G cap of
mRNAs. However, cellular stress such as hypoxia triggers the activation of 4EBP1 by inhibiting
its phosphorylation by mTOR kinase, resulting in the competitive displacement of eIF4G from
eIF4E and subsequent disassembly of the eIF4F complex shutting down cap-dependent translation.
Interestingly, despite this stress induced shutdown of cap-dependent translation, a few cellular
mRNAs have been shown to maintain translation using various alternative cap-independent
mechanism(s) (15-17).

1.2.1 Eukaryotic cells Express Multiple eIF4G-like Proteins
Human eukaryotic initiation factor 4G (eIF4G) is a multipartite binding protein that
mediates translation initiation by interacting with several eIFs to recruit the 43S PIC to the mRNA
(18). There are two homologs of eIF4G; eIF4GI and eIF4GII (Fig. 1.2) (19). The eIF4GI is
abundantly expressed (>85%) compared with eIF4GII (20). At the amino acid level,both homologs
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share a 46% identity and an overall 56% similarity (19). Either protein have been suggested to
share same biochemical activities and functionaly complement each other (21). Specifically,
eIF4GII have been proposed to promote translation of developmental mRNAs as well as mRNAs
involved in cell proliferations (22,23) while eIF4GI is involved in general mRNA translation as
well as specific translation of mRNAs involved in mitochondrial activity and bioenergetics (24).
Both homologs have several domains that provide the platform for interaction with other initiation
factors. The N-terminal region of the eIF4G homologs contain domain that interacts with the Poly
(A)-binding protein (PABP) which facilitates circularization of mRNA through its interaction
PABP protein at the 3’ end of mRNAs (25). There is also an 4E-binding motif (4E-BM) that
mediates interaction with the cap-binding protein, eIF4E, at the 5’ cap of eukaryotic mRNAs (26).

Figure 1.2. Schematic representation of the domain architecture showing conparisons of eIF4GI,
eIF4GII and DAP5 across different eukaryotic species. Various protein interacting domains are
shown; PABP (PABP protein domain), 4E-BM (eIF4E binding domain), MIF4G (RNA/eIF4A and
eIF3 binding domains), MA3 (eIF4A binding domain) and W2 (MNK 1/2 substrate binding
domains).
7

Notably, the middle domain, MIF4G, has the RNA binding domain which mediates its
interaction with cellular mRNAs, the eIF4A and eIF3 domains allow it to interact with the eIF4A
protein and eIF3 respectively, to recruit the small ribosomal subunit to the 5’ UTR of cellular
mRNAs. Apart from the central eIF4A binding domain, the MA3 region provides an additional
eIF4A binding sites. The central eIF4A-binding domain stimulates the helicase activity of eIF4AI
whilst the C-terminal domain functions in modulating the activity of eIF4AI (27) (28). At the Cterminus of both homolog is a regulatory region, W2, that binds to MAPK-interacting protein
kinases, MNK 1 or MNK 2 to phosphorylates eIF4E (29,30).
DAP5/p97/NAT1 is a more distant functional homolog of eIF4G (Fig.1.2) (19). The
homology of DAP5 to eIF4GI is highly confined to the C-terminal two-thirds (MIF4G) and shares
43% sequence identity with eIF4GII’s MIF4G domain (31) (Fig.1.2). It, however, lacks eIF4E and
PABP binding domains and has been suggested to be expendable in cap-dependent translation
(32). The W2 domain of DAP5 protein is a regulatory region that binds to MINK 1/2 as well as
the beta subunit of eIF2 (eIF2β) (29,33). DAP5 protein can undergo post-translational modification
to produce a C-terminal truncated form of the protein (p86) that cannot interact with eIF2β (34,35).

1.2.2 DAP5 mediates Translation of Subset of mRNAs
DAP5 was initially proposed to be a translational repressor as it shares similar eIF4A and
eIF3 binding sites with eIF4G protein. However, various studies have shown that DAP5 facilitates
cap-independent translation of subset of mRNAs such as p53, Bcl2, and DAP5 IRES and it is
functionally different from eIF4G (31,33,34,36). Further, the overexpression of the truncated form
of DAP5 (p86) has been linked with the cap-independent activity of mRNAs containing IRES in
their 5’ UTR (c-Myc, Apaf-1, XIAP, and c-IAP1/HIAP2) cells during preferential stress
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conditions such as apoptosis and endoplasmic reticulum (ER) stress (37-39). These subset of
mRNAs that are target of DAP5 have a complex secondary and tertiary structures at their 5’ UTRs
and high GC contents (36,40).

1.3. Cap-Independent Translation Initiation Mechanisms
Cap-independent translation is fundamental to cell survival particularly under stressed
conditions when there is reduced global protein synthesis. Such stressful conditions compromise
general mRNA translation but they also stimulate translation of subset of stress response mRNAs
using an unknown cap-independent translation mechanism (1). It is responsible for the onset and
maintaining progression of several human breast cancers, viral infections, and other biological
processes (41-43). Cap-independent protein synthesis mechanisms are unique in requiring fewer
eukaryotic initiation factors (elFs) than their cap-dependent counterparts (1). Although significant
progress has been made in the translation field to decipher this process, the exact mechanism (s)
through which proteins are synthesized in a cap-independent manner remains unclear. Myriads of
mechanisms describing cap-independent mechanism has been proposed (1,17,44,45).
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Figure 1.3. Pathway describing the canonical cap-dependent and nono-canical cap-independent
translation initiation mechanisms. Inactivated 4EBP1 allows the formation and recruitment of the
eIF4F complex at the m7G cap of the mRNAs. Stressful conditions inhibit mTOR, leading to active
4EBP1 which binds and sequester eIF4E from the eIF4F complex. Certain mRNAs (e.g VEGF,
p53, HIF-1α that have regulatory elements at their 5’UTR recruits the 43 S PIC with the help of
few eIFs to initiate a cap-independent translation mechanism (1,46,47).
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1.3.1. IRES-mediated Cap-Independent Translation Initiation Mechanism
Cap-independent translation initiation has emerged as an alternative mechanism by which
ribosomes initiate translation from certain translation enhancer elements called Internal Ribosome
Entry Site (IRES) within the 5’ UTR of mRNAs. This selective mode of protein synthesis was first
discovered in picornaviruses and lots of extensive studies have been done on this virus and other
viral mRNAs such as encephalomyocarditis virus (EMCV) (48-50). Most viral genome lacks the
m7Gp cap structure and therefore rely on this highly structured and stable RNA sequences to recruit
the ribosomes and synthesize proteins(51). Viral IRES-mediated translation initiation has been
categorized into various classes based on their initiation factor (s) requirement (Fig. 1.3b). While
it has been shown that some viruses harness just a subset of the canonical elFs and/ IREStransactivation Factors (ITAFs) for protein synthesis, other viruses bypass all canonical elFs and
directly recruits the 40 S ribosome for initiation (Fig. 1.3.1).
Recent high through-put studies using bicistronic reporter assays and deep sequencing have
demonstrated the presence of IRESs at the 5’ UTR of a subset of eukaryotic mRNAs (52). It is
speculated that these mRNAs use these structural elements to recruit key eIFs and 43S PICs at the
5’ UTR to survive under conditions when cap-dependent translation is compromised (17). While
cap-independent translation in viral systems is ubiquitous and widely researched biochemically
and structurally(16,51,53), similar, non-canonical translation mechanisms of cellular mRNAs are
poorly understood.
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Figure 1.3.1. Purported models for mechanisms of IRES-mediated translation initiation in viral
systems. Reproduced with permission from Richard J. Jackson et al. Nat Rev Mol Cell Biol, 2010,
11, 113-127. Copyright (2010) Springer Nature.

1.3.2. CITE-mediated Cap-Independent Translation Initiation Mechanism
Cap-Independent Translation Elements/Enhancers (CITEs) are sequences within the 5’
UTR of a subsets of cellular mRNAs that can presumably bind a few canonical factors and aid in
12

the recruitment of ribosome to initiate translation when stressful conditions inactivate the capbinding protein, eIF4E (15,17) (Fig. 1.3.2). Unlike the IRES-mediated translation initiation where
the ribosome is recruited to or close to the AUG with/without the aid of eIFs (Fig. 1.3.2B), CITEmediated translation initiation recruits the ribosome to the free 5’end of mRNA with the help of
eIFs and then scans in a 5’-to-3’ direction to the start codon (15). CITEs have been studied
extensively in plant viruses (54-56). Unlike cellular mRNAs that harbor CITE at their 5’ UTR,
most plant viruses contain these structures at their 3’ UTR (3’ CITEs). A number of studies have
demonstrated that plant virus use these 3’CITE elements to recruit ribosomes at the 3’ UTR and
subsequently engage the 5’ UTR via a long distance kissing loop interaction resulting in
circularization of the mRNA(54,57-60). This is followed by scanning mediated by eIF4A, eIF4B,
eIF3 and the eIF4GI scaffolding protein (Fig. 1.3.2A) to the start codon.

B.
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C.

Figure 1.3.2. Mechanisms of cap-independent translation initiations A. Carton of CITE-mediated
cap-independent initiation in cellular mRNAs and B. Cartoon of IRES-mediated translation
initiation during eIF4E sequestration by 4EBP1. Figures A and B were reproduced with permission
from Shatsky et al.,Trends Biochem Sci. 2018, 43(11):882-895. Copyright (2020) Elsevier. C.
3’CITE-dependent translation initiation in plant viral system. Adapted from (60).
1.3.3 Other Cap-independent Translation Mechanisms
Cellular mRNAs containing N6-methyladenosine (m6A) in their 5′ UTR have recently been
shown to mediate cap-independent translation during cellular stress that impairs m7Gp cap
recognition (Fig. 1.3.3A) (44). By using cell free extract and ribosome profiling studies, it was
shown that eIF3 binds specifically to the m6A and recruit the 43S PIC to initiate translation in a
cap-independent manner (44,61).

14

Figure 1.3.3. Non-canonical translation initiation mechanisms A. Cartoon showing a model of
how certain mRNAs containing m6A in their 5’UTR translate during heat shock stress conditions
B. Cartoon showing how the eIF3d can recognize and bind to the m7G to drive translation in an
eIF4E-independent manner during heat shock stress conditions that impairs the eIF4F assembly.
Figures were extracted from (44,62) Figures extracted with permission from A. Meyer et al., Cell.
2015, 163(4):999-1010. Copyright (2020) Elsevier and B. Reproduced with permission from Lee
AS et al., Nature. 2016, 536(7614):96-99. Copyright (2020) Springer.
The eukaryotic initiation factor, eIF4E is widely accepted as the cap-binding protein that
recognizes and binds to the m7G cap of mRNA to initiate translation in a cap-dependent manner
(10). However, recent structural and biochemical studies have shown the eIF3 subunit ‘d’ (eIF3d)
bind to the m7Gp structure of proliferating mRNAs (e.g. C-Jun) (Fig.1.3.3B) and with the help of
Death Associated Protein 5 (DAP5), drives translation initiation in a cap-dependent but eIF4Eindependent manner (63-65).
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1.4. Some EIFs Implicated In Cap-Independent Translation Initiation
1.4.1. Eukaryotic Initiation Factors 4GI (eIF4GI) and 4EBP1
Current studies have shown overexpression of eIF4G and 4EBP1 during different stages of
breast tumor development in large advanced breast tumor cancer specimen (LABC) (41). Western
blot analysis in 3 different cancer cell lines namely MCF10A cells (immortalized human breast
epithelial cells), CRL1902 cells (early stage-derived primary breast cancer cells), and BT474 cells
(late stage-derived highly transformed breast cancer cells) demonstrated a substantial increase in
eIF4G and 4EBP1 levels in highly transformed breast cancer cell lines. Overexpression of eIF4G
and 4EBP1 was coupled with increase translational turnovers of key mRNAs that drives tumor
development (e.g. VEGF and HIF-1α). Magnifying the roles of eIF4G and 4EBP1 in capindependent translation, it was determined that under hypoxic conditions, knockdown of eIF4GI
or a deletion mutant of 4EBP1 suppressed translation of VEGF Importantly, the fact that the
translational barrier imposed by 4EBP1 overexpression (and sequestration of eIF4E) was rescued
by an overexpression of eIF4G suggest a role for eIF4G in cap-independent translation. A
bicistronic assay using IRES of VEGF and HIF-1α showed a significant increase in their capindependent translation activity under hypoxic conditions (41) suggesting that these proangiogenic mRNAs may contain enhancer elements in their 5’ UTR that mediate non-canonical
cap-independent translation initiation mechanism.
1.4.2. Death-Associated Protein 5 (DAP5)
DAP5/p97/NAT1 has been described to play a role in the cap-independent translation of a
subset of mRNAs. This applies to

Apaf-1, Bcl2, DAP5 and p53 whose translation were

downregulated following knockdown of DAP5 in rabbit reticulocyte lysates and HeLa cell lysates
(33,66). The addition of recombinantly purified DAP5 rescued the translation of these mRNAs
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indicating that DAP5 mediate cap-independent translation of these mRNAs. Despite the
physiological outcome and widespread evidences for the role for eIF4GI and DAP5 in capindependent translation, there are no direct evidence for these eukaryotic initiation factors (eIFs)
interaction with structured elements (IRESs/CITEs) within the 5’ UTRs and how these eIFs may
facilitate a switch from cap-dependent to cap-independent translation in stressed conditions.
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1.5. Purpose and Specific Aims of Proposed Study
General mRNA translation occurs via cap-dependent translation mechanism in cells
(1,3,10). However, activation of the 4E-BPs during stressful conditions results in sequestration of
the cap-binding protein, eIF4E, leading to shutoff of cap-dependent translation (1,15). However,
stress response proteins maintain translation of their mRNAs using a poorly understood capindependent translation mechanism. Understanding the mechanistic insight into how these
mRNAs are translated under stressful conditions is crucial for the development of novel
therapeutics.
There have been few studies in recent years on cap-independent translation initiation in
cellular mRNAs (1,15,67). Some studies posits that these mRNAs that are translated under
stressful conditions have highly structured 5’ leaders or untranslated regions (UTR) that are able
to recruit the 43 S PIC with the aid of key initiation factors (15). Some of these structured mRNAs
are speculated to recruit the 43 S PIC to the free 5’ end and therefore acts as Cap-Independent
Translation Enhancers (CITE) whereas others do not require a free 5’ end and therefore acts as an
Internal Ribosome Entry Sites (IRES) (15). Regardless of whether these mRNAs structures acts as
a CITE or IRES elements, they control gene expression during translation and splicing in both
normal and disease conditions (68). Further, eukaryotic initiation factor 4GI (eIF4GI) and its
homolog, death-associated protein 5 (DAP5), are also overexpressed under these stress conditions,
suggesting the possibility that these proteins might play a role in the cap-independent translation
of many stress response mRNAs or oncogenic mRNAs that drives the development of many
diseases including cancers, tumor growth and other neurological disorders (44,63-66,69).
Therefore, given the gap in knowledge about the exact role of eIF4GI and DAP5 in capindependent translation initiation, and how a subset of human mRNAs containing structures in
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their UTRs that acts as IRES or CITE elements switch from cap-dependent to cap-independent
translation during stress conditions have motivated this research project.
1.5.1. Hypothesis and Specific Aims
The central hypothesis for this project is that, structured elements within the 5’ UTRs of
human mRNAs, also known as IRESs or CITEs, directly bind to eIF4G or DAP5, thereby
recruiting 43S PIC to activate the cap-independent translation pathway. Whilst there are strong
scientific evidences in support of this hypothesis, the mechanistic underpinning of how mRNAs
with structured 5’ UTRs recruit eIF4GI or DAP5 is yet to be elucidated. To test this hypothesis,
we proposed the following specific aims.

1.5.1a. Specific Aim 1:
To investigate the binding of eIF4GI constructs and DAP5 to the structured 5’ UTRs of
selected human mRNAs. Given the important role of mRNA structures on gene expression, we
aim to characterize whether this subset of human mRNAs encoding the 5’ UTRs of HIF-1α, FGF9, and p53 interact directly with eIF4GI and/ DAP5 using a fluorescence anisotropy-based
equilibrium binding assay. This assay is well-established for quantifying the binding affinity
between nucleic acids and proteins and has been used by several research groups (70,71). We
anticipate that this assay will enable us to study the interaction between our selected 5’ UTRs and
proteins and the equilibrium binding constant (Kds), which provides a measure of the binding
affinity for this interaction will be compared to the Kds for the interaction of these proteins with an
unstructured polyUC control as a measure to discriminate between binding of proteins to
structured and unstructured 5’ UTRs. Further, we will use the natural 5’ UTR of β-actin which
lacks IRES/CITE as another control to characterize the binding specificity.
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1.5.1b. Specific Aim 2:
Correlate the selective binding of each 5’ UTR to their cap-independent translational activity,
using luciferase-based gene expression system in nuclease-treated rabbit reticulocytes lysate.
To identify and test whether the cap-independent translation activity of these subset of mRNAs
(HIF-1α, FGF-9, and p53) is directly dependent on the availability of eIF4GI or DAP5, each
candidate 5’ UTR will be cloned upstream of a firefly luciferase gene and the resulting reporter
mRNA, capped with a non-functional cap analog (ApppG) will be translated in a nuclease-treated
rabbit reticulocytes lysate (RRL) which has been largely depleted of either eIF4GI or DAP5.
Further, to establish causality between the cap-independent activities of these mRNAs and the
proteins, recombinantly expressed eIF4GI and/DAP5 will be added back to the depleted lysate to
determine whether it can rescue their cap-independent activities. The RRL translation system is
not very cap-dependent unless under appropriate ionic strength conditions (25). We will optimize
conditions to maximize the translation efficiency for both cap-dependent and cap-independent
mRNAs. Further, using an engineered stable stem loop at the 5’ termini of our reporter constructs,
we will distinguish amongst the selected mRNAs for those that are translated either using IRES or
CITE-mediated mechanism of initiation. To achieve this, we will be comparing the capindependent translation activities of our reporters with free 5’ end to those with a stable hairpin
inserted at the 5’ end.

1.5.1c. Specific Aim 3:
To investigate the effect of additional initiation factors on the recruitment of eIF4G to 5’
UTRs of selected mRNAs and gene expression. To understand the mechanisms by which these
structured 5’ UTRs employ during cap-independent mechanism, we will examine the roles of
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additional initiation factors such as eIF4A, eIF4B and eIF4E using equilibrium binding assays..
With reporters generated in specific aim 2, we will investigate the gene expressions of these
mRNAs using the RRL system, in the presence of an eIF4A inhibitor, Rocaglamide and eIF4E
inhibitor, 4EGI-1 to characterize the functional role of eIF4A and eIF4E, respectively in the capindependent activities of these mRNAs. We envision that the results from these studies will shed
more light on the different initiation factor requirements by these mRNAs.
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2.1 Abstract
During unfavorable human cellular conditions (e.g., tumor hypoxia or viral infection), canonical,
cap-dependent mRNA translation is suppressed. Nonetheless, a subset of physiologically
important mRNAs (e.g., HIF-1α, FGF-9, and p53) is still translated by an unknown, capindependent mechanism. Additionally, expression levels of eIF4G and its homolog, death
associated protein 5 (DAP5), are elevated. By examining the 5’ UTRs of HIF-1α, FGF-9, and p53
mRNAs and using fluorescence anisotropy binding studies, luciferase reporter-based in vitro
translation assays, and mutational analyses, we demonstrate that eIF4GI and DAP5 specifically
bind to the 5’ UTRs of these cap-independently translated mRNAs. Surprisingly, we find that the
eIF4E binding domain of eIF4GI increases not only the binding affinity, but also the selectivity
among these mRNAs. We further demonstrate that the affinities of eIF4GI and DAP5 binding to
these 5’ UTRs correlate with the efficiency with which these factors drive cap-independent
translation of these mRNAs. Integrating the results of our binding and translation assays, we show
that eIF4GI and/or DAP5 are critical for recruitment of a specific subset of mRNAs to the ribosome
and provide mechanistic insight into their cap-independent translation.
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2.2 Introduction
Translation of mRNAs into proteins is the most energy consuming process in the cell (2,41)
and plays a major role in the regulation of gene expression. In eukaryotes, initiation of cellular
mRNA translation generally occurs via a ‘cap-dependent’ pathway in which eukaryotic initiation
factor (eIF) 4E binds to the N7-methylguanosine-triphosphate (m7GpppN, where N is any
nucleotide) ‘cap’ at the 5’ end of the mRNA to be translated (1,10). Cap-bound eIF4E subsequently
recruits eIF4G, which, together with eIF4A, recruits a ribosomal 43S pre-initiation complex (PIC)
composed of the 40S ribosomal subunit, a methionylated initiator tRNA (Met-tRNAiMet), and
additional eIFs, to the m7GpppN cap. Subsequent scanning of the resulting 48S PIC to find the
AUG start codon on the mRNA and joining of the 60S ribosomal subunit to the 48S PIC results in
the formation of an elongation-competent 80S IC that can go on to translate the mRNA.
In addition to undergoing cap-dependent initiation, many cellular mRNAs can also initiate
translation via ‘cap-independent’ pathways in response to changes in cellular conditions (16). The
ability of these mRNAs to switch from cap-dependent to cap-independent modes of translation
initiation plays an important role in maintaining normal cellular physiology (72) as well as in the
cellular response to diseases such as cancer, diabetes, and, possibly, neurological disorders
(42,43,73-76). A subset of cellular mRNAs, for example, has been shown to successfully bypass
a global suppression of translation initiation that is caused by stress conditions such as tumor
hypoxia, viral infection and nutrient deprivation, (10,16,67) and that is driven by the sequestration
of eIF4E by hypophosphorylated 4E-binding proteins (4E-BPs). While translation initiation of
these mRNAs under these conditions is often referred to as cap-independent, it may be more
accurately described as eIF4E-independent. Nonetheless, we will use the term cap-independent
here to refer to translation initiation that does not involve eIF4E-based recruitment of other eIFs
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to the m7GpppN cap. Many of the stress conditions that result in suppression of cap-dependent
initiation also result in increased expression levels of eIF4GI (42,73) and/or death associated
protein 5 (DAP5) (also called p97, NAT1 or eIF4G2) (34,77), suggesting that these two proteins
may be involved in cap-independent initiation mechanism(s).
The subset of mRNAs that is translated cap-independently under stress conditions as
described above are predicted to contain highly stable structures in their 5’ untranslated regions
(UTRs) that may act as internal ribosome entry sites (IRES) or cap-independent translation
enhancers (CITEs) (16,78). IRES-like mechanisms involve direct recruitment of the ribosome to
structured IRESs that are close to the AUG start codon (16,53), while CITE-like mechanisms
involve direct recruitment of eIFs to structured CITEs near the 5’ end of the mRNA, where the
eIFs are then thought to initiate cap-independent translation via 48S PIC scanning to the AUG start
codon (15,17). Although chemical and enzymatic probing of cellular mRNAs thought to contain
IRESs/CITEs have revealed stem loops, pseudoknots, and other structures (79,80), no common
sequence or structural motifs have been identified to allow prediction of cellular IRESs/CITEs
from mRNA sequence data. Regardless of whether their structured 5’ UTRs act as IRESs or CITEs,
the ability of these mRNAs to bypass the 4E-BP-mediated global suppression of cap-dependent
initiation has been linked to enhanced tumor development and cancer progression (41).
The overexpression of eIF4GI and DAP5 during stress conditions in which global capdependent translation initiation is suppressed implicates these two factors in cap-independent
translation. DAP5 is a member of the eIF4G family that is homologous to the C-terminal twothirds of eIF4GI (Fig. 2.1A) and that interacts with other known eIFs in manners that are both
similar and distinct to that of eIF4GI. Specifically, DAP5 and eIF4GI share 39% sequence identity
in the central core region that comprises the eIF4A-, eIF3-, and RNA-binding domains (31) (Fig.
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2.1B). Consistent with its similarity to the domain structure of eIF4GI, DAP5 interacts with eIF4A
and the eIF3 component of the 43S PIC (31). Notably, however, DAP5 lacks the N-terminal,
eIF4E- and polyadenine binding protein (PABP)-binding domains that are present in eIF4GI and,
consequently, does not interact with eIF4E or PABP (Fig. 2.1A). Also, the β subunit of eIF2 (eIF2β)
that interacts with the ternary complex formed by eIF2, GTP, and Met-tRNAi (81) binds to the Cterminal domain of DAP5, but not to the corresponding domain in eIF4GI. Collectively, these
differences between DAP5 and eIF4GI suggest differences in translation initiation mechanisms
involving these two eIFs (34). For example, rather than interacting with eIF4E to recruit factors to
the m7GpppN cap in cap-dependent initiation of mRNAs, DAP5 has instead been shown to mediate
the cap-independent initiation of a subset of mRNAs, including those encoding Bcl2, Apaf-1, p53,
and DAP5 itself (33,36). With the exception of p53 mRNA, which contains a structural element
that functions as an IRES and has been shown to bind DAP5 using electrophoretic mobility shift
assay (EMSA) studies (36), there have not yet been any studies aimed at investigating whether
mRNAs translated cap-independently directly recruit eIF4GI and/or DAP5 to the 5’ UTRs and
how such recruitments might drive the switch from cap-dependent to cap-independent initiation in
response to cellular stress. To address these gaps in our understanding, we used a fluorescence
anisotropy-based equilibrium binding assay to measure the affinities with which two variants of
human eIF4GI, one that lacks the N-terminal, eIF4E-binding domain (eIF4GI682-1599) and one that
contains the eIF4E binding domain (eIF4GI557-1599), as well as full-length human DAP5, bind to
RNA oligonucleotides corresponding to the 5’ UTRs of a representative set of mRNAs. These
mRNAs bypass (41) the 4E-BP-mediated global suppression of cap-dependent initiation and
encode HIF-1α, FGF-9, and p53. These mRNAs were chosen because HIF-1α and FGF-9 have
been shown to be translationally upregulated in hypoxic conditions
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where cap-dependent

translation is suppressed and where eIF4GI and 4EBPI levels are overexpressed (41,46). p53
mRNAs were chosen because these mRNAs are known to interact with DAP5 as part of a capindependent translation mechanism (36). Complementing these binding assays, a luciferase-based
gene expression reporter assay was used to characterize whether and to what extent binding of
eIF4GI682-1599, eIF4GI557-1599, and/or DAP5 promotes the translation of luciferase-encoding
mRNAs containing these same 5’ UTRs (UTR-Luc mRNAs) in a rabbit reticulocyte lysate-based
cap-dependent in vitro translation system. Using this assay with UTR-Luc mRNA constructs that
either lack or have a highly stable, engineered hairpin near the 5’ end of the 5’ UTR that blocks
initiation from the 5’ end, has further allowed us to investigate whether these mRNAs use an IRESlike or CITE-like mechanism of translation initiation. The results of our experiments demonstrate
that eIF4GI682-1599, eIF4GI557-1599, and DAP5 exhibit differential binding affinities to the 5’ UTRs
of the mRNAs encoding HIF-1α, FGF-9, and p53; that the eIF4E-binding domain of eIF4GI
confers additional binding affinity and specificity; and that binding affinity positively correlates
with the abilities of these eIFs to drive translation of these same UTR-Luc mRNAs. Moreover, the
inhibition, or lack thereof, of translation initiation by the engineered hairpin suggests that some
of these mRNAs use an IRES-like mechanism of translation initiation which does not require an
exposed 5’ end, while others use a CITE-like mechanism (82). Based on our observations, we
propose that unlike cap-dependent translation where binding of eIF4E to the m7G-cap is the initial
event in protein synthesis, an important initial event in cap-independent initiation of eukaryotic
cellular mRNAs with structured 5’UTRs, is binding of eIF4GI or DAP5. These 5’ UTR structured
mRNAs selectively recruit eIF4GI or DAP5 to drive expression of the proteins they encode, similar
to the cap-independent initiation of CITE- or IRES-containing viral mRNAs (51,60,83).
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2.3 Results
2.3.1 eIF4GI and DAP5 bind specifically and with differential affinities to the 5’ UTRs of a
subset of cellular mRNAs
To characterize the binding of eIF4GI and DAP5 to the 5’ UTRs of the mRNAs encoding
HIF-1α, FGF-9, and p53, we used a fluorescence anisotropy-based equilibrium binding assay
developed in our laboratories (Fig. 2.1A). This assay produces binding curves from fluorescence
anisotropy changes that arise as titrated proteins bind to RNA oligonucleotides that are covalently,
5′-end labeled with fluorescein and that lack a m7GpppN cap. Four RNA oligonucleotides
comprising the 5’ UTRs of mRNAs encoding HIF-1α, FGF-9, and the two 5’ UTRs of p53, were
assayed. The two p53 5’ UTRs represent the two 5’ UTRs involved in translation of the two distinct
isoforms of p53. Each p53 5’ UTR contains elements that select for translation initiation at either
an upstream start codon (p53A) or a downstream start codon (p53B), which produce the full-length
p53 (FL-p53) or an N-terminal-truncated isoform (ΔN-p53), respectively (47). When eIF4GI6821599,

eIF4GI557-1599, or DAP5 binds to one of the fluorescein-labeled 5′ UTRs, there is an increase

in molecular weight of the 5’ UTR that increases the rotational restriction as the system becomes
more rigid resulting in a decrease in the rotational speed of the fluorescein-labeled 5’ UTR. The
slower rotation is observed as increased fluorescence anisotropy of the fluorescein reporter. To
quantify the affinity of eIF4GI557-1599, eIF4GI557-1599, and DAP5 binding to the four 5′ UTRs, we
recorded the change in the fluorescence anisotropy of each fluorescein-labeled 5’ UTR as a
function of increasing concentrations of eIF4GI682-1599, eIF4GI557-1599, and DAP5 and fitted the
resulting data points with a single-site, equilibrium-binding isotherm (Fig. 2B, 2C and 2D). The
results of these experiments (Table 2.1) demonstrate that eIF4GI682-1599, eIF4GI557-1599, and DAP5
bind to the four 5′ UTRs with equilibrium dissociation constants (Kds) ranging from 12–290 nM
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(Table 2.1).
Comparative analyses of our results demonstrate that eIF4GI682-1599, eIF4GI557-1599, and
DAP5 exhibit differential binding affinities among the 5′ UTRs. Specifically, eIF4GI682-1599 binds
to the p53A 5′ UTR with a Kd that is ~2-fold higher (i.e., binding that is ~2-fold weaker) than that
with which it binds to the other 5’ UTRs (Table 2.1). DAP5 exhibited an even greater difference
in binding affinity among the 5′ UTRs, with a Kd for the p53B 5′ UTR that is more than 2.5-fold
lower than the Kd for the p53A 5′ UTR. It is important to note, however, that the trend of the
differences in binding affinities between the two translation factors (eIF4GI682-1599 and DAP5) for
the 5′ UTRs is similar. However, dramatic differences in binding among the 5’ UTRs were
observed for eIF4GI557-1599. Inclusion of the eIF4E-binding domain in eIF4GI557-1599 relative to
eIF4GI682-1599 increased the binding affinity of eIF4GI557-1599 from 1.8-fold (p53B 5’ UTR) to 10fold (FGF-9 5’ UTR) compared to those measured for eIF4GI682-1599. Further, the differences in
binding affinity among the 5’ UTRs were as much as 7-fold different compared to an
approximately 2-fold difference among the 5’ UTRs for eIF4GI682-1599. Taken together, these
results suggest much of the specificity of eIF4GI binding to the 5’ UTRs is conferred by the eIF4Ebinding domain (i.e., residues 557-682) of eIF4GI.

2.3.2 The binding of eIF4GI and DAP5 is specific to the 5’ UTRs of the selected mRNAs
In order to further investigate whether binding of eIF4GI and DAP5 to RNA depends on
structural features within the RNA and to contextualize and validate the results of the binding
studies above, we assessed the binding of eIF4GI682-1599, eIF4GI557-1599, and DAP5 to a presumably
unstructured, 101-nucleotide poly(UC) RNA oligonucleotide and an oligonucleotide encompassing the 5’ UTR of the mRNA encoding β-actin, which has been reported to utilize a cap-
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dependent mechanism for translation initiation (84). The results of these experiments demonstrate
that eIF4GI682-1599, eIF4GI557-1599, and DAP5 do not exhibit appreciable binding to the polyUC
oligonucleotide (Fig. 3A, B and C and Table S2.1) nor to the β-actin 5’ UTR, findings consistent
with the hypothesis that structural features within the 5’ UTRs of our subset of RNAs act as specific recognition elements and binding sites for eIF4GI and DAP5.
Previously, we have shown that eIF4F (a complex composed of eIF4GI, eIF4A, and eIF4E)
binds to the 30-nucleotide iron responsive element (IRE) stem-loop within the 5’ UTR of the
mRNA encoding ferritin with a Kd of 9 nM, a binding interaction that stimulates ferritin mRNA
translation in response to elevated cellular concentration of iron (85). Using the fluorescence
anisotropy-based equilibrium binding assay, here we show that eIF4GI682-1599, eIF4GI557-1599, and
DAP5 bind to the IRE with Kds of 18 nM, 15 nM and 35 nM, respectively (Fig. 3 and Table S2.1).
Similarly, we performed experiments in which we quantified the affinity of eIF4GI682-1599,
eIF4GI557-1599, and DAP5 for the J/K domain of the IRES in the 5’ UTR of the positive strand
genomic RNA, encoding the encephalomyocarditis virus (EMCV) polyprotein (Fig. 3.1 and Table
S2.1). These experiments show that eIF4GI682-1599, eIF4GI557-1599, and DAP5 bind to the EMCV
J/K IRES with Kds of 175 nM, 63 nM, and 519 nM, respectively. The Kd for binding of eIF4GI6821599

to EMCV J/K IRES RNA is similar to what has been previously reported for the binding of

human eIF4GI (643-1076) to the EMCV J/K IRES using EMSA (170 nM, (28)) as part of the
mechanism through which eIF4GI drives expression of the EMCV polyprotein in human cells (86).
The same report showed that a construct containing an N-terminal portion of DAP5 (62-330) did
not bind to the EMCV J/K IRES, consistent with our much higher Kd (519 nM) for full-length
DAP5 compared to eIF4GI constructs binding.
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2.3.3 The 5’ UTRs of a subset of cellular mRNAs that bind eIF4GI and DAP5 can drive
cap-independent translation
Having demonstrated that eIF4GI and DAP5 bind specifically and with relatively high
affinity to the 5’ UTRs of HIF-1α, FGF-9, p53A, and p53B, we examined the cap-independent
translation of a set of reporters containing these 5’ UTRs. To quantify the cap-independent
activities of our selected mRNAs, the 5’ UTRs of the HIF-1α, FGF-9, p53A, and p53B mRNAs and,
as a control, the 5’ UTR of β-actin mRNA were cloned upstream of a luciferase reporter gene (Fig.
2.4A). The resulting capped, polyadenylated UTR-Luc mRNAs were translated using a nucleasetreated, rabbit reticulocyte (RRL)-based, cap-dependent, in vitro translation system containing a
natural abundance of the eIFs. To assess cap-independent luciferase expression, a non-functional
cap analog (ApppG) was used to cap the UTR-Luc mRNAs (hereafter referred to as the ApppGcapped transcripts). The cap-independent expression levels of the ApppG-capped transcripts were
compared with the expression observed when these transcripts were capped with a functional
m7GpppA cap. We observed that the activities of the ApppG-capped transcripts ranged from ~70%
for FGF-9 UTR-Luc mRNA to 8% for p53B UTR-Luc mRNA when compared to their
corresponding m7GpppA-capped transcripts (Fig. S2.1). Expression of the ApppG-capped β-actUTR-Luc mRNA was reduced to less than 2% of the corresponding m7GpppA-capped construct
(Fig. S2.1). These results further support the notion that the 5’ UTR of a subset of cellular mRNAs
can drive cap-independent translation, albeit at a relatively lower efficiency than cap-dependent
translation. During stressful conditions in which cap-dependent translation is inhibited and
expression of eIF4GI and DAP5 are elevated, expression from these 5’ UTRs can help cells
mitigate the effects of the stressor (41).
The eIF4E-eIF4GI interaction allows recruitment of the eIF4F complex to the m7G cap of
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mRNAs (87). 4EGI-1 is a small-molecule that binds to the same site on eIF4E that interacts with
eIF4GI and inhibits the interaction of eIF4GI and eIF4E (88,89). In order to further support the
idea that translation initiation of these mRNAs was independent of eIF4E, we determined the
extent to which translation of the m7GpppA- and ApppG-capped transcripts were affected by
4EGI-1. Cap-dependent initiation was significantly suppressed through the addition of 4EGI-1 to
m7GpppA-capped β-act-UTR-Luc mRNA, but had no effect on the ApppG-capped transcripts of
our selected 5’ UTRs, with the exception of the ApppG-capped HIF-1α transcript, which exhibited
an ~44 % reduction in translation (Fig. S2.2). These results show that, to a large extent, translation
of the ApppG-capped transcripts proceeds via an eIF4E-independent mechanism. The observation
that the ApppG-capped HIF-1α transcript expression is partially reduced suggests that eIF4E might
not function exclusively during cap-dependent translation initiation, but may also play an
important role in the cap-independent translation initiation of some mRNAs. For example, eIF4E
has been shown to stimulate the helicase activity of eIF4A in the case of some highly structured 5’
UTRs (90), such as HIF-1a, and/or to induce conformational changes in eIF4G that enhance its
binding to mRNAs (91).

2.2.4 eIF4GI and DAP5 stimulate and restore cap-independent in vitro translation of the
selected 5’ UTR-Luc mRNAs
Having established that eIF4GI and DAP5 bind specifically and with relatively high
affinity to the HIF-1α, FGF-9, p53A, and p53B 5’ UTRs and that the corresponding UTR-Luc
mRNAs are translated through a cap-independent pathway, we sought to establish the extent to
which this cap-independent translation initiation of these mRNAs was dependent on eIF4GI and
DAP5. To accomplish this, we used our luciferase-based reporter assay and first determined the
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effects on translation of depletion of either eIF4GI or DAP5. We measured the luciferase activity
produced by each ApppG-capped transcript in an RRL that had been depleted of either endogenous
eIF4GI (RRL(-)4GI) or DAP5 (RRL(-)DAP5) using antibodies directed against these proteins. Western
blots confirmed successful depletion of eIF4GI or DAP5 (Fig. 2.4B) from the RRLs. As a control
to test for the indirect depletion of other eIFs, eIF4E, eIF2β, and eIF4A levels were tested in
RRL(-)4GI or RRL(-)DAP5 and were found to be similar to, or only slightly reduced from, those seen
in RRL (Fig. S2.3). Using either RRL(-)4GI or RRL(-)DAP5, we measured the luciferase activity
produced by each translation reaction of ApppG-capped transcript and compared it to RRL
translation assays of the same transcript without depletion of endogenous eIF4GI or DAP5. To
confirm the eIF4GI or DAP5 dependence on the translation initiation of these UTR-Luc mRNAs,
we added increasing concentrations of exogenous eIF4GI557-1599, eIF4GI682-1599, or DAP5 to the
corresponding depleted RRL. Translation of UTR-Luc mRNAs were significantly reduced in the
depleted RRLs compared with the RRL control (Fig. 2.4 C-F). Specifically, the translation output
of HIF-1α, FGF-9, p53A, and p53B ApppG-capped UTR-Luc mRNAs were reduced by 70 %, 67 %,
51 %, and 70 %, respectively, in RRL(-)4GI (Fig. 2.4C-F). Addition of eIF4GI557-1599 or eIF4GI6821599, significantly rescued and stimulated the cap-independent translation initiation of all four UTR-

Luc mRNAs (Fig. 4 C-F). For RRL(-)4GI, eIF4GI557-1599 restored translation of the ApppG-capped
transcripts to ~85-100% of the levels observed in RRL whereas eIF4GI682-1599 was slightly less
effective, restoring levels to ~70-90 % of the RRL levels for the same transcripts (Fig 2.4 C-F). In
the case of RRL(-)DAP5, the translation outputs of HIF-1α, FGF-9, p53A, and p53B ApppG-capped
UTR-Luc mRNAs were reduced by 83 %, 67 %, 63 %, and 81 %, respectively. Addition of DAP5
was also able to rescue cap-independent translation initiation of all four UTR-Luc mRNAs,
although with somewhat less efficiency compared to the eIF4GI constructs. DAP5 restored
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translation to ~45-65% of the levels for the same transcripts in RRL (Fig. 2.4C-F). These data
follow the same overall trend as our fluorescence anisotropy-based binding assay data where
eIF4GI557-1599 showed the highest binding affinity and DAP5 the lowest affinity to the 5’ UTRs
(Table 2.1).
Further demonstrating the cap-dependence of translation, the ApppG-capped β-act-UTRLuc mRNA showed less than 2% of the translation output as compared to the corresponding
m7GpppA-capped transcript (Fig S2.1). In agreement with our binding results, eIF4GI682-1599,
eIF4GI557-1599, and DAP5 did not show any significant stimulation of the cap-independent
translation of this ApppG-capped β-act-UTR-Luc mRNA (data not shown). Significantly, although
depletion of eIF4GI and DAP5 from the lysate decreased the translation of m7GpppA-capped βact-UTR-Luc mRNA to ~18% and ~67% respectively, only eIF4GI557-1599 construct containing the
eIF4E binding domain rescued its translation (Fig. S2.4), results that are consistent with the
previous and widespread use of this mRNA as a control for cap-dependent initiation and translation
(84). As expected, neither eIF4GI682-1599 nor DAP5 rescued the translation of the control m7GpppAcapped β-act-UTR-Luc mRNA (Fig. S2.4) as demonstrated by the absence of any significant
change in luciferase activity, indicating the specificity of the stimulation.

2.2.5 An exposed 5’ end is important for the cap-independent translation activities of HIF1α and p53A UTR-Luc mRNAs, but not FGF-9 and p53B UTR-Luc mRNAs
In order to gain a better mechanistic understanding of the cap-independent translation
initiation of our selected mRNAs, we introduced a stable hairpin at the 5’ end of our mRNAs (Fig.
2.5A). This same hairpin at this same position has been previously used to block scanning from
the exposed 5’ end of an mRNA while having no effect on the internal translation initiation
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mediated by an IRES (33,82,92). We found that the hairpin structure significantly repressed
translation of m7GpppA-capped β-act-UTR-Luc mRNA (Fig. 5B), which served as a positive
control for inhibition of 5’-end-scanning-dependent translation initiation. Comparative analyses of
our selected UTR-Luc mRNAs showed that the hairpin did not affect the translation initiation
activities of FGF-9 UTR-Luc mRNA (Fig. 5D) and p53B UTR-Luc mRNA (Fig. 5F), suggesting
that internal initiation occurred on these UTR-Luc mRNAs. In contrast, the translation efficiencies
of HIF-1α Luc mRNA (Fig. 5C) and p53A UTR-Luc mRNA (Fig. 5E) were significantly reduced
by the hairpin, suggesting that translation of these UTR-Luc mRNAs required an exposed 5’ end
for translation initiation and that these 5’ UTRs contain structural elements that may act as CITEs
rather than IRESs.
2.3 Discussion
In this study, using a fluorescence anisotropy-based equilibrium binding assay and a
luciferase-based gene expression reporter assay, we have demonstrated that eIF4GI and DAP5
directly bind to and stimulate cap-independent translation initiation of a subset of cellular mRNAs.
The truncated eIF4GI proteins, eIF4GI557-1599 and eIF4GI682-1599, as well as DAP5 bind to the 5’
UTRs of this subset of mRNAs with Kds in the range of 12-290 nM (Fig. 2, 3 and Table 2.1) and
stimulate cap-independent translation of the corresponding UTR-Luc mRNAs by 2-5 fold over
lysates depleted of either eIF4GI or DAP5 (Fig. 2.4 C-F). These Kds are comparable
to those observed for the binding of eIF4GI constructs to the EMCV J/K IRES (Fig. 2.3 and
Table S2.1), a well characterized system in which it has been previously shown that binding
of truncated eIF4GI643-1076 to a well-defined structural feature within the 5’ UTR of EMCV
mRNA stimulates the cap-independent translation of this mRNA (28). In line with cellular data
(41,77), our observations strongly suggest that both eIF4GI and DAP5 recognize and bind to
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specific structural features within the 5’ UTRs of our selected mRNAs. Moreover, the
observation that eIF4GI682-1599 and DAP5 bound to our selected 5’ UTRs with similar binding
affinities (Fig. 2.1 and Table 2.1) suggest that eIF4GI and DAP5 recognize similar elements within
the various 5’ UTRs. Furthermore, the intriguing differences between the Kds for the larger
construct of eIF4GI557-1599 and DAP5 (Table 2.1) suggest that, to bring about translational
outcomes, cellular mRNAs with structured 5’ UTRs may preferably recruit eIF4GI, depending on
its cellular availability, which may change by the type of stress conditions, cell-type, or stability
of the proteins (38,41,93).
Several reports have demonstrated that a subset of cellular mRNAs possess IRES-like
elements in addition to the cap structure, and that these mRNAs act to recruit ribosomal PICs and
presumably key eIFs internally to the 5’ UTR of these mRNAs in order to initiate cap-independent
translation (16,41,94). However, no common structural motifs were identified among the cellular
IRES elements and, compared to viral IRES, cellular IRES elements appear to be much more
diverse and less stable in terms of Gibbs free energy of folding (95). In contrast to these reports, it
has recently been proposed that other cellular mRNAs may recruit ribosomal PICs in an capindependent manner to the 5’ end using a CITE that recruits eIFs, and that the ribosomal PIC then
scans from the 5’ end rather than using an IRES to initiate translation internally (15). Given the
fact that some 5’ UTRs may possess either IRESs and/or CITEs, we were prompted to test the
hypothesis that the exposed 5’ end of our selected 5’ UTRs is required for translation. Our data
showed that the presence of a highly stable, scanning-inhibiting hairpin (92,96) at the 5’ end of the
FGF-9 and p53B ApppG-capped hp-UTR-Luc mRNAs did not affect the absolute translation levels
of these mRNAs (Fig. 2.5), demonstrating that they were cap-independently translated,
presumably using IRES-like mechanisms. In contrast with this, the hairpin at the 5’ end of the
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HIF-1a and p53A ApppG-capped hp-UTR-Luc mRNAs repressed the cap-independent translation
initiation activities of these UTR-Luc mRNAs (Fig. 2.5), suggesting that accessibility of the 5’
end of these cellular mRNAs is necessary and, correspondingly, a CITE-like mechanism is
important for the initiation of these mRNAs. Because the subset of cellular mRNAs we have
investigated here employ different systems of cap-independent translation, we speculate that this
phenomenon may provide additional regulation for the expression of these mRNAs.
Our findings are reminiscent of the manner in which viruses use highly structured IRESs
to directly recruit eIFs, the 40S subunit, and/or the 43S PIC to drive the cap-independent
translation of viral mRNA (16,97,98). Although the mechanisms through which viral mRNAs
use IRESs to drive cap-independent initiation have been extensively characterized using genetic,
biochemical, and structural approaches (66,69,78), the mechanisms through which eukaryotic
cellular mRNAs drive cap-independent initiation remain largely unknown. Nonetheless, an
increasing body of evidence suggests eukaryotic cellular mRNAs can employ non-canonical initiation
mechanisms that are distinct from those employed by IRES-containing viral mRNAs. For
example, Cate and co-workers have recently shown that the ‘d’ subunit of eIF3 (eIF3d) targets
mRNAs encoding proteins involved in cell proliferation and serves as a transcript-specific, cap-binding
protein (64). Using the mRNA encoding the c-Jun transcription factor as an example, these authors
showed that, under conditions in which an RNA structure in the 5’ UTR blocks eIF4E from binding
to the 5’ cap, eIF3d binds directly to the 5’ cap and serves as an alternative cap-binding factor
(63). Even more recently, it has been shown that DAP5 is a direct binding partner of eIF3d and it
has been proposed that DAP5 uses eIF3 to direct the eIF4E-independent, cap-dependent translation
of a subset of cellular mRNAs when cellular stress conditions lead to inactivation of eIF4E (65). In
addition to these mechanisms in which RNAs utilize IRES elements, eIF3d, or other eIFs that
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function as alternative cap-binding proteins, the methylation of adenosine residues in the 3’- and
5’ UTRs of eukaryotic cellular mRNAs have been shown to stimulate translation by an unknown
mechanism (44,61). The cellular IRES- and CITE-based mechanisms we have investigated here
are distinct from these other types of mechanisms that make use of an alternative cap-binding
protein or post-transcriptional modification of the mRNA to be translated. Here, eIF4GI or DAP5
completely bypass any cap-dependent processes and are instead directly recruited to IRESs or
CITEs within the mRNAs. Indeed, because the binding studies we present here employ
purified eIF4GI557-1599, eIF4GI682-1599, and DAP5 and uncapped RNA oligonucleotides, our results
show these translation factors can bind directly to 5’ UTRs of select mRNAs in a completely capindependent manner and without the need of alternative cap-binding proteins or mRNA methylation. Similarly, because

the gene

expression

assays we

present

here

also

employed purified mRNAs with non-functional cap analogs and are performed in RRL, RRL(-)4GI
and RRL(-)DAP5 we can be confident that the stimulation of translation we observe is due to the
direct interaction of eIF4GI or DAP5 with the IRES or CITE elements in the 5’ UTRs of our
selected mRNAs, rather than to the indirect effects of alternative cap-binding proteins or
methylation of the mRNA.
Based on our observations, we propose that an important initial event in cap-independent
initiation of eukaryotic cellular IRES- or CITE-containing mRNAs is binding of eIF4GI or DAP5,
similar to the cap-independent initiation of CITE- or IRES-containing viral mRNAs (51,60,83).
Specifically, we propose that eIF4GI or DAP5, perhaps with the aid of additional factors, bind to
elements within the 5’ UTRs and subsequently recruit additional eIFs, the 40S subunit, and/or the
43S PIC to these mRNAs. In analogy to the cap-independent initiation of several CITEcontaining viral mRNAs (51,57,60) we propose that the resulting 48S PIC may then scan to
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the AUG start codon. Our data suggest that this is the case for the for HIF-1α and p53A mRNA.
Alternatively, these factors may be bound to elements near the AUG acting as IRES-like structures
as appears to be the case for FGF-9 and p53B (Fig. 2.6). It is not surprising that multiple mechanisms and eIF requirements may be present with different and possibly dynamic RNA structures
in the 5’ UTR having different requirements. This is certainly the case for viral cap-independent
translation (98).
The transition from cap-dependent to cap-independent translation of cellular mRNAs under
stress conditions has important physiological consequences, particularly in disease states, such as
diabetes, cancer, and possibly neurological disorders (42,43,73-76). Under stress conditions, the
levels of 4EBP1, eIF4GI, and DAP5 are elevated (34,41,42,73,77). Here we have identified key
interactions of eIF4GI and DAP5 through which cellular mRNAs containing either IRESs or
CITEs may bypass the 4EBP1-mediated depletion of eIF4E and undergo cap-independent
initiation and expression. Identification of specific interactions that facilitate the transition from
cap-dependent to cap-independent translation promises to facilitate a better understanding of noncanonical translation mechanisms and to inform the potential development of novel therapies that
modulate this transition in order to regulate the cellular response to stress conditions.

2.4 Experimental procedures
2.4.1 Preparation of RNAs for fluorescence anisotropy-based equilibrium binding studies
DNA templates corresponding to the 5’ UTR of HIF-1α (294 nts, GenBank Accession Number:
AH006957.2) (99), the 5’ UTR of FGF-9 (177 nts, GenBank Accession Number: AY682094.1)
(46), the 5’ UTR for one isoform of p53 (p53A) (136 nts, GenBank Accession Number:
JN900492.1), the 5’ UTR for a second isoform of p53 (p53B) (117 nts, GenBank Accession
Number: MG595994.1) (47,66), the ferritin IRE (100), the EMCV J/K IRES (nts 680-786) (28,69),
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the 101-nucleotide polyUC, and the 5’ UTR of β-actin (84 nts, GenBank Accession Number
AK301372.1) (84) were purchased from Integrated DNA Technology (IDT) and the corresponding
RNAs were synthesized via in vitro transcription using the HiScribeTM T7 Quick High Yield
RNA Synthesis Kit (New England Biolabs Inc.) following the manufacturer’s protocol. RNA from
transcription reactions were purified using the RNA Clean and Concentrator (RCC) Kit from Zymo
Research following the manufacturer’s protocol. Purified RNA transcripts were labeled with
fluorescein at their 5’ termini using the 5' EndTag DNA/RNA Labeling Kit from Vector
Laboratories following the manufacturer’s protocol. RNA concentrations were determined using
nano-drop UV/Vis spectrometer and integrity was verified by 1.5%. agarose gel electrophoresis.

2.4.2 Preparation of eIF4GI557-1599, eIF4GI682-1599, and DAP5
The plasmids for expression of eIF4GI557-1599, and eIF4GI682-1599 were a generous gift from Dr.
Christopher Fraser (University of California at Davis). Full length eIF4GI purified from cells as
part of the eIF4F complex is easily degraded during purification and is contaminated with varying
amounts of eIF4E and/or eIF4A. We therefore used stable, functional constructs described here
(101-103). The codon-optimized eIF4GI682-1599 construct (34) includes the minimal sequence for
IRES-mediated cap-independent translation initiation (31) and is similar in domain structure to
full-length DAP5. This construct has an N-terminal, 6x-histidine tag followed by a Flag tag in
pET28c vector. We introduced a Tobacco Etch Virus (TEV) protease cleavage site following the
Flag tag using the Q5® Site-Directed Mutagenesis Kit from New England Biolabs Inc following
the manufacturer’s protocol. The eIF4GI557-1599 construct was in fastback vector. It was PCR
amplified using a forward primer containing a NcoI site and a 6x-histidine tag followed by a TEV
protease site and a reverse primer containing an XhoI site. The amplified PCR product was
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subcloned in pET28c at the NcoI-XhoI site and used to express and purify the eIF4GI557-1599 protein.
The plasmid encoding full-length human DAP5 with an N-terminal 6x-histidine tag was purchased
from Genscript (Piscataway, NJ). All the proteins were recombinantly expressed in E. coli BL21CodonPlus (DE3)-RIL cells (Agilent) and were purified using a combination of Ni2+-nitro-triacetic acid (Ni-NTA) affinity and heparin affinity columns, as previously described (25,34).
Briefly, the proteins were first purified from bacterial cell lysates using His-Trap HP (Ni-NTA)
columns (GE Healthcare Life Sciences), as per the manufacturer’s instructions. The purified 6xhistidine tagged proteins were dialyzed overnight against Storage Buffer (20 mM HEPES-KOH
pH 7.6, 200 mM KCl, 10 mM β-mercaptoethanol, 10% glycerol) in the presence of TEV protease
to cleave off the tags. The untagged proteins were further purified and concentrated using 1 mL
HiTrapTM Heparin HP columns (GE Healthcare Life Sciences). The eluted proteins were analyzed
on 10% SDS-PAGE gels and pure fractions (>95% purity) were pooled and dialyzed overnight
against Storage Buffer. The concentrations of the purified, concentrated proteins were quantified
using Coomassie Protein Assay Reagent (Thermo Scientific) and were aliquoted and stored at 80°C.

2.4.3 Fluorescence anisotropy-based equilibrium binding assays
Fluorescein-labeled RNAs were diluted to 100 nM using Folding Buffer (20 mM HEPES-KOH
pH 7.5 and 100 mM KCl) and heated to 90 °C for 2 min and slowly cooled over 1 hr to room
temperature. MgCl2 was then added to the solution to a final concentration of 1 mM, the solution
was gently mixed and incubated on ice for about 1 hr. Fluorescence anisotropy measurements for
assessing the binding of eIF4GI constructs or DAP5 to the fluorescein-labeled RNAs were
performed using the equilibrium titration module of an SF-300X stopped-flow fluorimeter
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(KinTek Corporation, Austin, TX). Fluorescein-labeled RNAs were excited at 495 nm and
emission was detected using a 515 nm high-pass filter (Semrock, Rochester, NY). Equilibrium
binding titrations began with a 200 μL sample of either 10 nM (Figures 2B and 3A) or 100 nM
(Fig. 2C-D and Fig. 3B-C) of fluorescein-labeled RNA in the Titration Buffer (20 mM HEPESKOH, pH 7.6, 100 mM KCl, and 1 mM MgCl2) and 20-50 data points were collected for each
anisotropy measurement by automated continuous injection of 20 μL of 2.5 μM of eIF4GI557-1599,
10 μM eIF4GI682-1599 or 10 μM DAP5 over a period of 30 min at a temperature of 25 °C. Note that
the first reading is taken in the absence of protein. Using the Origin 2018b software package, the
data were fitted to a nonlinear, single-site, equilibrium binding equation of the form:
robs = rmin + (rmax − rmin )[

[eIF4GI or DAP5]
]
𝐾! + [eIF4GI or DAP5]

where robs is the observed anisotropy value, rmin is the minimum anisotropy value in the absence
of eIF4GI or DAP5, rmax is the final saturated anisotropy value, [eIF4GI or DAP5] is the
concentration of eIF4GI557-1599, eIF4GI682-1599, or DAP5, and Kd is the equilibrium dissociation
constant. The chi-squared values (χ2) that represented the statistical goodness of fit were always
close to 1 and are reported in Table 2.1. Fitting data to a two-site model did not improve the fit as
judged by (χ2) values. The equilibrium binding titration of each 5’ UTR was performed three times
and fit independently for Kd. The fitted Kds were then averaged and the standard deviations were
calculated (Table 2.1).

2.4.4 Preparation of UTR-Luc reporter mRNAs for luciferase-based gene expression
reporter assays
The UTR-Luc mRNA constructs for the luciferase gene expression reporter assays were generated
from the BlucB plasmid (104), which contains a firefly luciferase gene flanked by 5’- and 3’ UTR
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sequences of the Barley Yellow Dwarf Virus (BYDV) genomic RNA. To generate each UTR-Luc
mRNA reporter construct, a sequence containing the T7 promoter followed by the target 5’ UTR
was cloned into the BlucB plasmid vector upstream of the firefly luciferase coding region, after
removing the BYDV 5’ UTR as follows. Briefly, all UTR-Luc reporter constructs were PCR
amplified with the forward primers containing a NotI site and reverse primers containing a BssHII
shown in Table 2.1 and then digested with NotI and BssHII. All the restriction enzymes were
purchased from New England Biolabs (NEB) and restriction digests were performed according to
the manufacturer’s instructions. The PCR-amplified sequences were ligated into a NotI- and
BssHII-digested BlucB plasmid using DNA ligase (NEB) and transformed into E. coli DH5-α
competent cells. Five colonies were selected, grown overnight in Luria-Bertani (LB) growth media
supplemented with 100 μg/mL ampicillin, and used to isolate plasmid DNA using the QIAprep®
Spin Miniprep kit from Qiagen and following the manufacturer’s protocol.
To assess whether the availability of a 5’ end is required for the translation of these reporter
mRNAs, a highly stable hairpin (92) was inserted at the 5’ end of each UTR-Luc reporter (hpUTR-Luc mRNA) using site-directed mutagenesis with the primers in Table 2.1. All clones were
confirmed by sequencing (Genewiz). To generate a linearized plasmid DNA template for in vitro
transcription, plasmid DNAs were linearized using KpnI so as to remove the 3’ UTR from the
UTR-Luc mRNA reporter construct. The resulting linearized DNA was purified using the
GeneJET gel extraction and DNA cleanup Micro Kit from GeneJET as per the manufacturer’s
instructions. DNA templates were in vitro transcribed using T7 RiboMax Large Scale RNA
Production Kit (Promega) following the manufacturer’s protocol. ApppG (NEB) or Ribo
m7GpppA Cap Analog (Promega) were added to the transcription mix in an ApppG or Ribo
m7GpppA:GTP ratio of 10:1 to get mRNA transcripts with non-functional and functional caps,
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respectively. Capped RNAs were polyA tailed (pA) using the Poly(A) Tailing Kit (Invitrogen)
following the manufacturer’s protocol. The resulting capped and polyadenylated mRNAs were
then purified using RNA Clean and Concentrator (RCC) Kit (Zymo) following the manufacturer’s
protocol. RNA concentrations were determined using nano-drop UV/Vis spectrometer and
integrity was verified by 1.0% agarose gel electrophoresis.

2.4.5 Western Blots and depletion of eIF4GI and DAP5 from the rabbit reticulocyte lysate
Monoclonal mouse primary antibodies for DAP5 (sc-137011), eIF4GI (catalog number sc373892), eIF4E (catalog number sc-9976), eIF2β (catalog number sc-9978) and eIF4AI/II (catalog
number sc-377315) (Santa Cruz Antibodies) were used for Western blot and/or
immunoprecipitation experiments. For the Western blot experiments, the specific antibodies were
diluted to 1:1000 in PBST (Phosphate-Buffered Saline-Tween) buffer containing 1% BSA. The
blots were incubated overnight in the primary antibodies at 4 ºC with constant shaking. The
membranes were washed three times with PBST and then incubated with horseradish peroxidase
(HRP)-goat anti-mouse secondary antibody (1:5000 dilution, Invitrogen, catalog number 31430)
for 1 hr at room temperature. After three subsequent washes in PBST, the membrane was
developed

using

enhanced

chemiluminescent

substrate

(SuperSignalTm

West

Femto,

Thermoscientific, catalog number 34094). For the depletion of eIF4GI and DAP5 from the RRL,
20 μL of either eIF4GI or DAP5 capture antibodies were incubated with PureProteomeTM Protein
A/G mix magnetic Beads (EMD Millipore Corporation) at room temperature with continuous
mixing for 1 hr. The bead-antibody complexes were washed for 10 secs with 500 μL PBS. The
bead-antibody complexes were captured using a magnetic stand (Promega) and the suspensions
were removed. The washing step was repeated 2 more times with PBS and then with the wash
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buffer (20 mM HEPES-KOH, pH 7.5, 50 mM KCl, 75 mM KOAc, 1 mM MgCl2). The nucleasetreated RRLs (Promega) were incubated with these preformed bead-antibody complexes at 4°C
with continuous shaking for 1 hr. The magnet was re-engaged to capture the bead-antibody-protein
complex and the resulting depleted RRL (RRL(-)4GI or RRL(-)DAP5) was collected and used for
translation. To determine the extent of depletion, Western blot assays were performed after
resolving the samples on a 4-15% Tris-HCl gradient gel (Bio-Rad Laboratories).

2.4.6 Luciferase-based gene expression reporter assays
Gene expression was achieved by translating the UTR-Luc mRNAs in vitro, using the nuclease
treated RRL in vitro translation system from Promega. The RRL was made more cap-dependent
by addition of 75 mM KCl (25). Each 25 μL reaction contained 70% v/v of RRL, RRL(-)4GI or
RRL(-)DAP5 (Promega) supplemented with 0.5 mM MgCl2, 0.02 mM amino acid mixture, 10 U/μL
RiboLock RNase Inhibitor (Thermoscientific), and varying concentrations of purified eIF4GI
constructs, or DAP5 as indicated in the figure legends. 4EGI-1 chemical (10mM Stock in DMSO)
(Selleck Chemicals, catalog number S7369) was added to the translation mix when indicated at a
concentration of 0.2 mM. Briefly, 1 μg of UTR-Luc mRNA was added to the RRL, RRL(-)4GI or
RRL(-)DAP5 in vitro translation mixture that had been pre-incubated at 30 °C for 10 min following
the addition of the specified concentration of eIF4GI constructs or DAP5. The resulting in vitro
translation reaction was then incubated at 30 °C for 1 hr and stopped by the addition of 60 μM
puromycin. Firefly luciferase activities were then assayed using a Glomax 96 microplate
illuminometer (Promega). To achieve this, 3 μL of translation reaction was added to 30 μL BrightGlo Luciferase assay reagent (Promega) and the resulting luminescence was measured in the
illuminometer over a spectral wavelength of 350–650 nm and an integration time of 10 s at room
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temperature. After subtracting the background, measured using an in vitro translation reaction to
which no UTR-Luc mRNA had been added, the luminescence data were analyzed and plotted
using the Prism 8 software package. At least 3 different batches of RRLs were used. The translation
data for each UTR-Luc mRNA were reported as an average of three independent experiments.
Each independent experiment was done in triplicate and the mean ± SD were calculated using
GraphPad Prism 8. Statistical significance between the mean values were analyzed using twotailed unpaired student’s t-test (GraphPad Prism 8 software). The statistical significance was set at
p < 0.05 and the p-values were calculated. The calculated p values for of the analyses are indicated
as follows on the brackets above the bar graphs (Figs. 4,5 and Supp. Figs 1,2 and 4. : n.s(nonsignificant), p=0.12; * , p =0.033 ; **, p =0.002; ***, p < 0.001.
2.4.7 Data availability
All data are present in the manuscript.
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Table 2.1. Parameters describing the equilibrium binding of eIF4GI constructs and DAP5 to the
5’ UTRs

eIF4GI557-1599

eIF4GI682-1599

5’ UTRs

Kd ± S.D.
(nM)

Amp.
(rmax–rmin)

χ2

Kd ± S.D.
(nM)

Amp.
(rmax–rmin)

HIF1a

50 ± 6.0

0.045

0.996

139 ± 23.0

0.034

FGF-9

12 ± 2.0

0.079

0.995

120 ± 7.0

p53A

86 ± 4.0

0.021

0.998

p53B

68 ± 19.0

0.025

0.998

DAP5
Kd ± S.D.
(nM)

Amp.
(rmax–rmin)

χ2

0.994

154 ± 18.0

0.061

0.988

0.027

0.996

136 ± 10.0

0.039

0.998

248 ± 16.0

0.036

0.999

290 ± 14.0

0.044

0.999

126 ± 4.0

0.017

0.998

112 ± 6.0

0.048

0.998

χ2

Table Footnote: Kd is the equilibrium dissociation constant, rmax–rmin is the amplitude which
indicates change in anisotropy and χ2 represent the goodness of fit.
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Table 2.2. Primers used for the cloning of the UTRs in reporter constructs
Reporters

Forward primers

Reverse Primers

HIF1α

5’-CTAGGCGGCCGCTAATACGAC-3’

5’-CTAGGCGCGCGGTGAATCGGTC-3’

FGF9

5’-CTAGGCGGCCGCTAATACGAC-3’

5’-CTAGGCGCGCCAGAGGACTCGGC-3’

p53A

5’-CTAGGCGGCCGCTAATACGAC-3’

5’-CTAGGCGCGCGGCAGTGAC-3’

p53B

5’-CTAGGCGGCCGCTAATACGAC-3’

5’-CTAGGCGCGCTGCTTGGGAC-3’

β-actin

5’-CTAGGCGGCCGCTAATACGAC-3’

5’-CTAGGCGCGCGGTGAGCTGG-3’

Primers used for insertion of a stable hairpin at the 5’UTR end of UTR-Luc constructs
Reporters

Forward primers

Reverse Primers

HIF1α

5’-AGGCCGTGCACAGTGCTGCCTCG-3’

5’-AGGCCAAGCCTATAGTGAGTCGTATTAG-3’

FGF9

5’-AGGCCGAAACAGCAGATTACTTTTATTTATG-3’

5’-AGGCCTATAGTGAGTCGTATTAGC-3’

p53A

5’-AGGCCGGTCTAGAGCCACCGTCC-3’

5’-AGGCCCTATAGTGAGTCGTATTAGCGG-3’

p53B

5’-AGGCCATGGAGGAGCCGCAGTCA-3’

5’-AGGCCCCCTATAGTGAGTCGTATTAGCG-3’

β-actin

5’-AGGCCACCGCCGAGACCGCGTCC-3’

5’-AGGCCCCTATAGTGAGTCGTATTAGCGCGCG-3’
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2.8 Figures and legends

Figure 2.1. Domain structure and sequence alignment between eIF4GI and DAP5 A. Cartoons
showing the domain architecture of eIF4GI557-1599 and full length DAP5. eIF4GI contains a second
eIF4A binding region in the MA3 domain (blue box in the eIF4GI cartoon), but the corresponding
domain in DAP5 (blue box with ?) does not bind to eIF4A, and has unknown function(31).The
shorter construct of eIF4GI, eIF4GI682-1599, is highlighted in the black box. B. Sequence alignment
encompassing similar domains in eIF4GI682-1599 and DAP5. The sequence alignment was
performed using T-coffee (59). Residues are color-coded according to their domain organization
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shown in A. C. A 10% SDS-PAGE gel showing purity of eIF4GI557-1599, eIF4GI682-1599, and DAP5
used for this study.

Figure 2.2. Equilibrium binding-titrations of 5’ UTRs with eIF4GI557-1599, eIF4GI682-1599, and
DAP5. A. Cartoon showing the fluorescence anisotropy-based equilibrium binding assay.
Normalized anisotropy changes for the interaction of fluorescein-labeled FGF-9 (-g-), HIF-1α (▼-), p53A (-●-) and p53B (-♦-) uncapped 5’ UTRs, with B. eIF4GI557-1599, C. eIF4GI682-1599, and
D. DAP5. Briefly, 10 nM (B) or 100 nM of fluorescein-labeled uncapped RNA oligos (C and D)
were titrated with increasing concentrations of eIF4GI557-1599, eIF4GI682-1599, or DAP5 in the
titration buffer at 25 °C and the anisotropy at each titration point was measured using excitation
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and emission wavelengths of 495 nm and 520 nm, respectively. Data points correspond to the
average of three independent anisotropy measurements and the curves represent the non-linear fits
that were used to obtain the averages and standard deviations for the corresponding Kd values
presented in Table 3.1.
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A.

B.

C.

Figure 2.3. Equilibrium binding titrations of fluorescein labeled ferritin IRE (-●-), EMCV J/K
IRES (-g-), b-actin UTR (-o-) and polyUC (-Ñ-) binding to A. eIF4GI557-1599 B. eIF4GI682-1599,
and C. DAP5. Briefly, 10 nM (A) or 100 nM of fluorescein-labeled uncapped RNA oligos (B and
C) were titrated with increasing concentrations of eIF4GI557-1599, eIF4GI682-1599, or DAP5 in the
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titration buffer at 25 °C and the anisotropy at each titration point was measured using excitation
and emission wavelengths of 495 nm and 520 nm, respectively. Average of 3 independent
experiments were performed and the curves represent the non-linear fits that were used to obtain
the averages and standard deviations for the corresponding Kds values given in Table S2.1.
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Figure 2.4. Effect of eIF4GI557-1599, eIF4GI682-1599, and DAP5 on the expression of ApppG cappedUTR-Luc mRNAs. A. Cartoon showing the design of ApppG-capped-UTR-Luc mRNA reporters
construct containing a structural element upstream of the firefly luciferase gene. B. Western blot
of eIF4GI and DAP5 depleted RRL probed using specific eIF4GI and DAP5 antibodies. Purified
recombinant eIF4GI682-1599 or DAP5 protein used for the study were included as positive controls
(Lane 1). The endogenous eIF4GI detected in RRL is full length (FL eIF4GI). Lane 2 shows nondepleted RRL; Lane 3 immuno-precipitate pulled down by antibodies for either eIF4GI (top panel)
or DAP5 (lower panel). dpRRL is the depleted RRL (RRL(-)4GI or RRL(-)DAP5). Lysates were run
on 4-12% SDS gradient gels and transferred to a nitrocellulose membrane. The effect of increasing
concentrations of eIF4GI557-1599, eIF4GI682-1599, and DAP5 on the translation yields of ApppGcapped transcripts of C. HIF-1α, D. FGF-9, E. p53A, and F. p53B ApppG-capped-UTR-LucmRNAs. Relative luciferase activity measured in RRL (Bar 1 or Bar 7) or RRL(-)4GI or RRL(-)DAP5
(Bar 2 or Bar 8) in the presence of increasing concentrations of either eIF4GI557-1599 (Bar 3-4),
eIF4GI682-1599 (Bar 5-6), and DAP5 (Bar 9-10). Relative luciferase activity was normalized to the
respective controls (ApppG-capped UTR-Luc mRNA) for each reporter performed in nondepleted RRL. Bar heights and error bars correspond to the average and standard deviations,
respectively, of three independent luciferase activity measurements. Data analyzed by two-tailed
unpaired Student’s t-test: **, p =0.002; ***, p < 0.001.
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Figure 2.5. Effect of a stable 5’ hairpin (hp) inserted at the 5’ terminal of UTR-Luc mRNAs. A.
Cartoon representation of the reporter construct used to test the effects of 5’ UTR accessibility of
HIF-1α, FGF-9, p53A, and p53B UTR-Luc mRNAs. B. Inhibition of 5’end dependent translation
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of m7GpppA-capped-β-act-UTR-Luc mRNA by a 5’hairpin. C-F. Comparison of the translation
output of reporters ApppG-capped-UTR-Luc mRNAs versus ApppG-capped-hp-UTR-Luc mRNA.
Data analyzed by two-tailed unpaired Student’s t-test: n.s, p =0.12; ***, p < 0.001.

Figure 2.6. Cartoon summarizing models for canonical (cap-dependent) and the proposed
cap/eIF4E independent translation initiation of the mRNAs containing structured 5’UTRs. The top
panel depicts normal physiological conditions where activated mTOR (mammalian target of
rapamycin) hyper phosphorylates 4EBP1, making it inactive. eIF4E binds to the m7G-capped
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mRNA to recruit other eIFs and the 43S PIC to initiate canonical cap-dependent translation. In the
lower panel, inactive mTOR leads to hypo phosphorylation of 4EBP1 which blocks eIF4E’s
interaction with eIF4GI. The 4EBP1-eIF4E complex may interact with the m7G-capped mRNA
but is unable to interact with eIF4GI. Our model shows eIF4GI or DAP5 binding the 5’ UTR and
recruiting the 43S PIC by either a CITE-like mechanism or an IRES-like mechanism.
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2.9 Supplementary data
Table S2.1. Parameters describing the equilibrium binding of eIF4GI mutants and DAP5
to 5’ UTRs
eIF4GI557-1599

eIF4GI682-1599

Control
UTRs

Kd ± S.D.
(nM)

Amp.
(rmax–rmin)

χ2

Kd ± S.D.
(nM)

Amp.
(rmax–rmin)

EMCV
J/K
IRES

63 ± 3.0

0.024

0.996

175 ± 4.0

0.031

Ferritin
IRE

15 ± 2.0

0.040

0.999

18 ± 2.0

polyUC

N.A

0.011

0.946

b-actin

N.A

0.007

0.998

DAP5
Kd ± S.D.
(nM)

Amp.
(rmax–rmin)

0.998

519 ± 21.0

0.045

0.988

0.076

0.997

35 ± 3.0

0.069

0.998

N.A

0.003

0.994

N.A

0.010

0.999

N.A

0.006

0.911

N.A

0.039

0.998
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χ2

χ2

Supplementary Figure. 2.1. Comparison of cap-dependent and cap-independent translation
activities of A. β-actin B.HIF-1α C. FGF-9, D. p53A and E. p53B, UTR-Luc mRNAs in RRL. The
RRL was made more cap-dependent by the addition of 75 mM KCl to the lysate (25). Luciferase
activities are the representative of mean of three independent experiments. Data analyzed by twotailed unpaired Student’s t-test: n.s, p =0.12; *, p < 0.033; ***, p < 0.001.
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Supplementary Figure. 2.2. Effect of 4EGI-1 on the translation yields of UTR-Luc mRNAs of
A. m7GpppA-capped β-act-UTR-Luc mRNA. B. ApppG-capped UTR-Luc mRNA of HIF-1α,
FGF-9, p53A, and p53B. The grey panel shows translation of the ApppG-capped UTR-Luc mRNA
in the absence of 4EGI-1 but a corresponding aliquot of DMSO added and the white panel depicts
translation in the presence of 0.2 mM of 4EGI-1. Data analyzed by two-tailed unpaired Student’s
t-test: n.s, p =0.12; ***, p < 0.001.
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Supplementary Figure. 2.3. Depletion of eIF4GI or DAP5 have little effect on eIF4E, eIF2β, and
eIF4A levels. eIF4E binds only to eIF4GI and not to DAP5, so the levels of eIF4E were tested in
RRL(-)4GI) only (Lane 3, left panel). Similarly, eIF2β has been shown to directly interact with DAP5,
but not eIF4GI(34), so only the RRL (-)DAP5 was tested for levels of eIF2β (lane 3, right panel).
Since eIF4A binds to both eIF4GI and DAP5, the eIF4A levels were tested in both RRL(-)4GI (lane
3, left pane), and RRL (-)DAP5 (lane 3, right panel). IP represents the protein pulled-down by the
immunoprecipitation.
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Supplementary Figure 2.4. Effect of eIF4GI mutants and DAP5 on the expression of m7GpppAcapped β-act-UTR-Luc mRNA. The lysate was depleted of eIF4GI (Bar 2-6) or DAP5 (8-10) and
the expression levels of m7GpppA-capped β-act-UTR-Luc mRNA was quantified following
addition of recombinantly purified eIF4GI557-1599 (Bar 2 and 3), eIF4GI682-1599 (Bar 4 and 5) and
DAP5 (9 and10). The RRL was made more cap-dependent by the addition of 75 mM KCl to the
lysate (25). Results were analyzed the same as Fig. 4. Bar heights and error bars correspond to the
average and standard deviations, respectively, of three independent luciferase activity
measurements and data analyzed by two-tailed unpaired Student’s t-test: n.s, p =0.12; *, p < 0.033;
**, p =0.002; ***, p < 0.001.
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CHAPTER 3
Investigating the roles of additional eukaryotic initiation factors in the recruitment of
eIF4GI to the untranslated region (UTR) of a subset of human mRNAs

* This work will be published in part as:
Haizel SA, Bhardwaj U, Goss DJ
Dissecting the roles of eIF4A, eIF4B and eIF4E in the recruitment of eukaryotic initiation factor
4GI (eIF4GI) to the untranslated region (UTR) of a subset of human mRNAs
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3.1 Abstract
In the previous chapter, we reported the binding affinities of eIF4GI and DAP5 to 5’UTRs of HIF1α, FGF-9 and p53) and showed how their cap-independent activities is dependent on the
availability of either eIF4G or DAP5. Based on our findings, we proposed a model describing two
cap-independent pathways namely; IRES-like or CITE-like mechanisms. However, there are
unresolved questions, such as what other initiation factors facilitate recruitment of eIF4GI or
DAP5 to these 5’ UTRs. In this chapter, we investigated how eIF4G interactors (eIF4A and eIF4E)
as well as eIF4B are differentially recruited to the 5’ UTRs of FGF-9 and HIF-1α. Our results
showed eIF4A, eIF4E and eIF4B significantly enhanced the binding affinity of eIF4GI to the 5’
UTR of HIF-1α compared to eIF4G only. In contrast, eIF4A, eIF4E and eIF4B did not enhance
the binding affinity of eIF4GI to the 5’ UTR of FGF-9 suggesting different eIFs requirement.
3.2 Introduction
Translation initiation is the rate-limiting step of protein synthesis and is a major target for
gene regulation especially during stress conditions (e.g. hypoxia, nutrient deprivation etc.)
(105,106). In general, initial steps in the canonical cap-dependent translation in eukaryotes
involves recognition and binding of eukaryotic initiation factor 4E (eIF4E) to the 5’ methyl
guanosine (5’ m7G) cap of mRNA (107,108). The eIF4E along with eIF4A and the eIF4G
scaffolding proteins constitute the eIF4F trimeric complex and together with eIF3, facilitates
recruitment of the 43 S Preinitiation complex (PIC) to the 5’ end of the mRNA to initiate protein
synthesis (1,10,108). However, during stress conditions, eIF4E interaction with eIF4G is inhibited
due to activated 4EBP1 (109,110). Although, under these conditions, when cap-dependent
translation pathway is compromised, a subset of mRNAs involved in stress responses are able to
translate using various non-canonical eIF4E/cap independent translation pathways (15,65) .
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Additionally, during these stress conditions, certain protein synthesis factors such as eIF4GI and
DAP5 are overexpressed (34,36,41). We recently reported that a prototype of these mRNAs
employ either an IRES-like or CITE-like cap-independent pathway driven by direct recruitment of
eIF4G or DAP5 to their structured 5’ untranslated region (111). However, the effects of other
eukaryotic initiation factors in the recruitment of these factors remain unknown. In this report we
show the effects of additional eukaryotic translation initiation factors eIF4A, eIF4B and eIF4E(?)
on this recruitment.
The eukaryotic initiation factor 4A is an ATP-dependent RNA helicase that binds RNA
and ATP cooperatively and unwinds secondary structures within the 5’ UTR to provide efficient
scanning of the 43 S PIC to the start codon (112). Generally, the requirement for eIF4A’s helicase
activity is dependent on the degree of secondary structure within the 5’ UTR of mRNAs (113).
eIF4A alone is not efficient in removing secondary structures but its unwinding activities is
facilitated by eIF4B (114) , eIF4E and eIF4G (115). As mentioned previously, the eukaryotic
initiation factor 4E is a cap-binding protein that is recruited to the 5’ m7G cap of cellular mRNAs
(116). Recently, it has been proposed that eIF4E may play a role in the cap-independent translation
of highly structured mRNAs by stimulating the unwinding of secondary structures (90).
Although the roles of eIF4A, eIF4E and eIF4B have been studied extensively in capdependent translation mechanism (115,117), little is known about their roles in cap-independent
mechanisms. Therefore, understanding the functional roles of these initiation factors, and how
these proteins interact with each other to facilitate a cap-independent mechanism will shed more
light on this underlying regulatory mechanism.
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In this work, we used equilibrium-binding assays to elucidate how these initiation factors;
eIF4G, eIF4A, eIF4E and eIF4B are recruited to the 5’ UTRs of FGF-9 and HIF-1α, either
individually or as a multi-protein complex. Further, using firefly luciferase reporter system, we
show the functional roles of eIF4A and eIF4E in the cap-independent activities of FGF-9 and HIF1α.

3.3 Results
3.3.1 Other eukaryotic initiation factors (eIFs) bind with different affinities to the 5’ UTRs
of FGF-9 and HIF-1α
Having shown previously that eIF4GI binds directly and specifically to structural elements
within the 5’ UTRs of FGF-9 and HIF-1α, our selected mRNAs, we began to dissect what other
canonical factors may enhance binding affinities of this protein to the 5’ UTRs and
correspondingly facilitate the cap-independent translations of these mRNAs. To test the hypothesis
that other eukaryotic initiation factors (eIFs) enhance binding of eIF4GI/DAP5 to the 5’ UTRs and
to understand how other eIFs may help recruit the mRNAs, we determined the binding affinities
of these eIFs bound to the 5’ UTRs (Fig. 3.1 and Tables 1 and 2). Our results showed that eIF4A
and eIF4B binds with differential binding affinities to these 5’ UTRs (Fig.3.1 C and D).
Specifically, we observed that eIF4B bound HIF-1α and FGF-9 with affinities of (54 ± 8.0) nM
and (35 ± 5.0) nM respectively whilst eIF4A bound to HIF-1α and FGF-9 with modest affinities
of (252 ± 20.0) nM and (667 ± 52.0) nM respectively (Fig. 3.1 and Tables 1 and 2). Both 5’ UTR
of HIF-1α and FGF-9 did not show any appreciable binding to eIF4E (Fig. 3.1 and Tables 1 and
2). As a control, none of the proteins, eIF4A, eIF4B and eIF4E bind to an unstructured polyUC
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(Fig. S2.1) consistent with the notion that structural elements within the 5’ UTR recognize and
bind to key initiation factors.

3.3.2 eIF4A and eIF4E enhance the binding affinity of eIF4GI557-1599 to the 5’ UTR of HIF1α mRNAs but not FGF-9
In order to test the hypothesis that eIF4A and eIF4E may improve the binding affinity of eIF4GI5571599 to the 5’ UTRs of FGF-9 and HIF-1α,

the fluorescein-labeled uncapped RNA oligonucleotides

were titrated with eIF4GI557-1599 in the presence of saturating amount of eIF4A (hereafter denoted
as eIF4GI+4A) or mixture of eIF4GI557-1599 and eIF4E (hereafter denoted as eIF4G+4E). We observed
that eIF4GI+4A bound HIF-1α with a Kd of (17 ± 2) nM compared with (50 ± 6) nM for eIF4GI5571599 only

(Fig. 3.2 and Table 3.2). This represented a 3-fold tighter affinity for eIF4GI557-1599 in the

presence of eIF4A compared with eIF4GI557-1599 only. This observation implies that eIF4A may
act synergistically with eIF4GI557-1599 to form a higher binding affinity complex that may facilitate
tighter binding to the HIF-1α 5’ UTR. In contrast, the binding affinity of eIF4GI+4A for the FGF9 5’ UTR (Kd = 16 ± 4 nM) did not improve compared to eIF4GI557-1599 only (Kd = 14 ± 3 nM)
(Fig 3.2 and Table 3.1). This may suggest that eIF4A did not enhance the interaction of eIF4GI5571599 on
1599.

the 5’ UTR of FGF-9 and thus, may not be required for the stable recruitment of eIF4GI557-

The eIF4GI+4E affinity for FGF-9 (Kd = 16 ± 3 nM) was not different from eIF4GI557-1599 only

(Kd = 14 ± 3 nM). Remarkably, we found out that eIF4GI+4E affinity for HIF-1α was bolstered by
the presence eIF4E (Kd = 15 ± 3 nM) compared to eIF4GI557-1599 only (Kd = 50 ± 3 nM) (Fig. 3.3B,
C and Table 3.2). This 3-fold increase in binding affinity in the presence of eIF4E suggest that
eIF4E may be required to stably recruit eIF4GI to the 5’ UTR of HIF-1α. These results were
consistent with our previous report where we demonstrated that inhibition of eIF4E repressed the
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translation of HIF-1α but not FGF-9 (111), further suggesting a possible role for eIF4E in HIF-1α
cap-independent translation mechanism. In another experiment, we showed that in the presence of
eIF4A, eIF4E and eIF4GI557-1599 (hereafter denoted as eIF4GI+4A+4E) the binding affinity to the 5’
UTR of HIF-1α is ~2-fold stronger compared to to eIF4GI557-1599 alone (Fig. S2, Table 3.2). This
is in contrast to the results obtained for the 5’ UTR of FGF-9 where the affinity for eIF4GI+4A+4E
(Kd = 33 ± 6) was 2-fold less compared to eIF4GI557-1599 alone (Kd = 14 ± 3 nM) (Fig. S2, Table
3.1).

3.3.4 ATP hydrolysis may not be important for efficient recruitment of eIF4GI to the 5’
UTRs of FGF-9 and HIF-1α
Because eIF4A plays key role in unwinding secondary structures within the 5’ UTRs of
mRNAs (25) and previous results had shown that it binds directly with modest affinity to the 5’
UTRs of both FGF-9 and HIF-1α (Fig. 3.1), we determined the effect of ATP hydrolysis on the
recruitment of eIF4GI to these mRNAs. To do this, we incubated the fluorescein labelled 5’ UTRs
of FGF-9 and HIF-1α with eIF4A, eIF4B and ATP and titrated increasing amount of eIF4G557-1599.
As a control, we used a non-hydrolysable ATP analog (AMPPNP). Our result indicated that ATP
hydrolysis did not improve the binding affinity of eIF4GI557-1599 to either 5’ UTR of FGF-9 or HIF1α. Importantly, we observed that the helicase complex without ATP (eIF4GI+4A+4B) had a 4-fold
increased binding affinity to the 5’ UTR of HIF-1α compared to eIF4GI557-1599 only (Fig. 3.1D,
3.4D and Table 3.2). In contrast, eIF4GI+4A+4B affinity to the 5’ UTR FGF-9 was comparable to
that obtained for eIF4GI557-1599 only (Fig. 3.4 A, C and Table 3.1). These results suggest that eIF4A
and eIF4B may be required for stable recruitment of eIF4GI to the 5’ UTR of HIF-1α but not FGF-
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9. Further, it is likely that the stable recruitment of eIF4GI to the 5’ UTR of HIF-1α in the presence
of eIF4A and eIF4B is independent of ATP hydrolysis.

eIF4E and eIF4A, may be required for Cap-independent activities of HIF-1α but not FGF9
To gain further insight into the functional role of eIF4A and eIF4E in the cap-independent
translation of FGF-9 and HIF-1α, we performed in vitro translation assays using a nuclease-treated
rabbit reticulocyte lysate and tested the effect of an eIF4A inhibitor, Rocaglamide, as well as an
eIF4E inhibitor, 4EGI-1 on their translation efficiencies. To this end, we generated a luciferase
reporter construct for each 5’ UTR (UTR-Luc-mRNAs) that were capped with a non-functional
cap-analog (ApppG) and observed the expression levels following addition of Rocaglamide, (Fig.
3.5 A and B) and 4EGI-1 (Fig. 3.5 C and D). By analyzing the relative firefly luciferase expression
for each candidate 5’ UTR, we observed a noticeably decreased translation activity in the presence
of increasing concentration of Rocaglamide although at a much higher concentration for FGF-9Luc-mRNA compared to HIF-1α-Luc-mRNA (Fig. 3.5 C and D). In comparison, we observed 8090% drastic decrease in translation yield in HIF-1α-Luc-mRNA compared with 17-67% decrease
for FGF-9-Luc-mRNA. We repeated the translation assay using increasing concentration of 4EGI1 molecule. We observed that the translation of FGF-9-Luc-mRNA was not significantly impacted
following addition of 4EGI-1(Fig. 3.5D) whilst HIF-1α-Luc-mRNA was partially reduced to 2045% of the control without the inhibitor (Fig. 3.5 E)
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eIF4A and eIF4E differentially stimulates the Cap-independent activities of HIF-1α and
FGF-9
To investigate if the decrease in translation yield of HIF-1α-Luc-mRNA and FGF-9-LucmRNA reporters by Rocaglamide was specific and due to eIF4A inhibition, we tested if addition
of purified eIF4A would rescue their cap-independent translation activities. Under this condition
of eIF4A inhibition by 60 nM Rocaglamide, we observed an increase in both the cap-independent
translation efficiencies of FGF-9 and HIF-1α following addition of purified eIF4A protein (Fig.
3.6). These results indicate that eIF4A is required for the optimal cap-independent translation of
these mRNAs. We next investigated the functional role of eIF4E in the cap-independent translation
of HIF-1α since 4EGI-1 molecule inhibited its translation but not that of FGF-9 (Fig. 3.5D, E). We
determined that following treatment of the lysate with 4EGI-1 (RRL(+)4EGI-1), the translation of
HIF-1α-UTR-Luc-mRNA was significantly restored by eIF4E (Fig. 3.6 C).
3.4 Discussion
Here, we report eIF4A and eIF4E as essential interactors of eIF4GI in the recruitment of
the highly structured 5’ UTR of HIF-1α to mediate a CITE-like cap-independent translation. We
also show that eIF4GI alone is sufficient to bind to the 5’ UTR of FGF-9, to mediate an IRESlike cap-independent translation. Previous report has already shown how eIF4GI is directly
recruited to the 5’ UTRs of these mRNAs and provided a mechanistic insight regarding the capindependent translation initiation of these mRNAs (111). In this report, we have now shown how
additional factors (eIF4A and eIF4E) are differentially recruited to the 5’ UTRs of HIF-1α and
FGF-9 to mediate either a CITE-like or IRES-like cap-indepndent translation.
Given that eIF4GI protein interact with several proteins including eIF4A, eIF4E etc to
mediate translation, we were interested in how eIF4A and eIF4E may influence the recruitment of
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eIF4GI557-1599 to the 5’ UTRs of FGF-9 and HIF-1α. Our binding data show that HIF-1α and FGF9 bind with different affinities to eIF4A and eIF4B whilst eIF4E did not bind to either 5’ UTRs
(Fig. 3.1, Tables 1 and 2). Further, we found out that, eIF4GI+4A and eIF4GI+4E complexes both
bound HIF-1α with a 3-fold tighter binding affinity compared with eIF4GI557-1599 only. This is
suggestive of a conformational change in the eIF4GI557-1599 in the presence of either eIF4A or
eIF4E that enhance stable and higher affinity binding to the 5’ UTR of HIF-1α. Other publications
have also demonstrated similar tighter binding affinity by eIF4G in the presence of eIF4A for
EMCV IRES (28). Interestingly, neither eIF4A nor eIF4E improved the binding affinity of
eIF4GI557-1599 for FGF-9 suggesting that eIF4GI alone is sufficient to stably bind to the 5’ UTR of
FGF-9. We posit that since FGF-9 is acting as an IRES rather than a CITE, it may require fewer
eukaryotic initiation factors to be recruited to its 5’ UTR (111). The role of eIF4A in the stable
binding of eIF4GI557-1599 to the 5’ UTR of HIF-1α was found to be independent of its helicase
activities (Fig. 3.4B) as ATP binding or hydrolysis are not required for efficient recruitment of
eIF4GI557-1599 (Fig. 3.4B). This was also found to be the case for FGF-9 5’ UTR (Fig.3.4A).
The role for eIF4A in the cap-independent activities of HIF-1α and FGF-9 was further
supported in an in vitro translation assay where addition of eIF4A inhibitor, Rocaglamide,
inhibited the translation output of these mRNAs. eIF4A is an important protein required for
resolving secondary structures within the vicinity of the start codon (112) and thus, inhibiting its
activities in the lysate disrupted the cap-independent activities of HIF-1α and FGF-9 (Fig. 3.5B,
C). For 5’ UTRs that are highly structured, as seen for the case of HIF-1α (Supplementary Fig.
S2), we observed a more drastic decrease in its cap-independent activities in the presence of lower
concentration of Rocaglamide compared with FGF-9 (Fig. 3.5B, C). One possible explanation for
this could be that HIF-1α employ a CITE-like cap-independent translation mechanism that requires
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recruitment of the 43 S PIC at its exposed 5’ end (111) and because it is also highly structured, it
is highly dependent on eIF4A to scan and unwind secondary structures upstream of the start codon.
This is in contrast to IRES-like mech that recruit 43 S PIC close to the start codon and may require
minimal or no unwinding activities by eIF4A (1). Consistent with the idea that eIF4A is important
for the translation of HIF-1α, we observed stimulation of its cap-independent activities following
addition of increasing concentrations of purified eIF4A to lysate treated with Rocaglamide, RRL(+)
RocA

(Fig. 3.6B). Intriguingly, although eIF4A did not improve the binding affinity of eIF4GI557-

1599

to the 5’ UTR of FGF-9, its cap-independent activities was inhibited in the lysate treated with

Rocaglamide (Fig. 3.6A). This suggest that other roles of eIF4A in translation such as the helicaseindependent recruitment of the PIC and modulating the conformation of the 40S ribosomal subunit
may have been affected by Rocaglamide (118). This results support the role of eIF4A in translation
of all mRNAs (112,113). Our results also identified eIF4E as important for the cap-independent
activities of HIF-1α but not FGF-9. Support for this conclusion is seen where 4EGI-1 molecule
inhibited the translation of HIF-1α but not FGF-9 (Fig.3.6D, E). Although it is established that
cap-independent translation is eIF4E-independent (15), it is likely the binding of eIF4E to eIF4GI
may cause a conformational change in eIF4GI that enhance its binding to the 5’ UTR of HIF-1α
as this is further supported by our binding (Fig. 3.4B, Table 3.2) and translation data (Fig. 3.6 C).
In conclusion, we report that eIF4A is crucial for efficient translation of HIF-1α mRNA
and FGF-9. Although the addition of eIF4A to the binding assay increased the affinity of eIF4GI5571599

for HIF-1α by 3-fold magnitude but had no effect on the 5’ UTR of FGF-9, both mRNAs were

stimulated by eIF4A in vitro in a lysate where eIF4A has been inhibited. This indicated that the
binding interaction between eIF4GI and eIF4A but not eIF4GI alone is necessary for the capindependent activities of these mRNAs. Additionally, eIF4E is important for the stable recruitment
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of eIF4GI557-1599 to the 5’ UTR of HIF-1α but may be dispensable in its cap-independent activity
in lysates. These data support our new model that eIF4A and eIF4GI plays important role in the
CITE-like cap-independent translation of HIF-1α and FGF-9 driven IRES-like cap-independent
translation (Fig. 3.7).
3.5 Experimental procedures
Preparation of RNAs for Binding Assays
DNA templates corresponding to the 5’ UTR of HIF-1α (294 nts, GenBank Accession Number:
AH006957.2) (99), the 5’ UTR of FGF-9 (177 nts, GenBank Accession Number: AY682094.1)
(46) and the 101-nucleotide polyUC were purchased from Integrated DNA Technology (IDT). The
DNA templates were transcribed using the T7 transcription kit (New England Biolabs Inc.)
following the manufacturer’s protocol. The transcribed RNAs were purified using the RNA Clean
and Concentrator (RCC) Kit from Zymo Research and following the manufacturer’s protocol. The
RNA concentrations were determined using nano-drop UV/Vis spectrometer and integrity was
verified by 1.5%. agarose gel electrophoresis. The RNAs were then labeled at the 3’ termini in an
oxidation reaction (119) using a final concentration of 30 μM RNA, 105 μM of NaOAc pH-5.2 and
15 mM of Sodium Periodate. Reaction tube was covered with aluminum foil and incubated for 30
min in the dark. After incubation, 1M Sodium Sulphite was added and incubated for an additional
10 min in a dark. Oxidation product was purified using ethanol precipitation. The purified oxidized
RNA was then used for labeling reaction by adding a final concentration of 1 mM of Flouroscein5-thiosemicarbazide (FTSC) and 50 mM Na-Phosphate buffer pH 6.5. Reaction was covered with
aluminum foil and incubated in the dark for 2 hours. After incubation period, 1 M NaCNBH3 was
added and the reaction was further incubated overnight at 4°C. After overnight incubation, labeled
product was purified using a two-step purification that involve ethanol precipitation and RNA
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Clean and Concentrator (RCC) Kit from Zymo Research and following the manufacturer’s
protocol. The RNA concentrations were determined using nano-drop UV/Vis spectrometer and
integrity was verified by 1.5% agarose gel electrophoresis.

3.5.2 Purification of Proteins
Human eIF4GI557-1599, eIF4E and eIF4A clones were a generous gift from Dr. Christopher S. Fraser.
The human eIF4B clone was obtained from Gonzalez Jr lab (Columbia University). The eIF4GI5571599 was

purified as previously described in (111). The eIF4A clone contained N-terminal His- and

MBP-tags followed by a TEV protease recognition site whilst the eIF4B contained only N-terminal
his-tag. Briefly, the eIF4A, eIF4B clones, were recombinantly expressed and purified from BL21
(DE3) cells. Induction of proteins were done using IPTG (0.5 Mm) for 3 hrs at 30°C after OD
confirmed @ A595 ̴ 0.5. Recombinant His-tagged eIF4A and eIF4B were then purified and
separated using Ni-NTA column (102) and were dialyzed overnight against the storage buffer (20
mM HEPES pH 7.3, 200 mM KCl, 1 mM DTT and 10% glycerol) to remove excess imidazole.
The tags were removed following TEV-protease digestion at 4°C overnight and the untagged
proteins were further purified using Heparin column. The human eIF4E/pCDF-duet clone had an
N-terminal polyhistidine tag, with a TEV protease cleavage site between the His-tag and the eIF4E.
For expression of recombinant eIF4E protein, E. coli Rosetta (DE3) was transformed with this
clone and bacterial cells from 1.5L of Luria Bertani (LB) medium were used. The bacterial cells
were grown at 37°C till the OD600 reached 0.6-0.8. Protein expression was induced overnight at
20°C, by adding IPTG (final concentration of 0.5mM). The cells were pelleted and sonicated in
the lysis buffer (25 mM HEPES pH 7.5, 300 mM KCl, 10% glycerol, 1 mM DTT, 20 mM
imidazole, with added protease inhibitor tablet). The supernatant was filtered through a 400 micron
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syringe filter, and loaded on a pre-equilibrated 5ml Ni-NTA column (pre-equilibrated with the
lysis buffer). The column was washed with 20 ml buffer E (25 mM HEPES pH 7.5, 300 mM KCl,
10% glycerol, 1 mM DTT, 50 mM imidazole), and the protein was eluted with buffer E containing
500mM imidazole. Fractions containing eIF4E were pooled and dialyzed overnight against buffer
E (without any imidazole) containing TEV protease, at 4°C. The dialyzed samples were further
purified on a 5 mL Q-Sepharose column to separate the untagged protein from the cleaved tag and
the TEV protease. Briefly, the KCl concentration of dialyzed samples was adjusted to 100mM and
the sample was loaded on a 5 ml pre-equilibrated Q-Sepharose column (pre-equilibrated with
buffer A- 25 mM HEPES pH 7.5, 100 mM KCl, 10% glycerol, 1 mM DTT). The proteins were
eluted using a step gradient of 150-500 mM KCl in buffer A. Fractions containing eIF4E, were
pooled, concentrated and stored at -80°C. Aliquots of purified proteins were analyzed by SDSPAGE gels (Supplementary Figure 1) and quantified using Bradford’s assay. The aliquoted
proteins were finally stored at -80°C in the storage buffer.
3.5.3 Fluorescence anisotropy-based equilibrium binding assays
Fluorescein anisotropy-based equilibrium binding assays were performed as previously described
(111). Briefly, Fluorescein-labeled RNAs were diluted to 100 nM using Folding Buffer (20 mM
HEPES-KOH pH 7.5 and 100 mM KCl) and heated to 90 °C for 2 min and slowly cooled over 1
hr to room temperature. MgCl2 was then added to the solution to a final concentration of 1 mM,
the solution was gently mixed and incubated on ice for about 1 hr. Fluorescence anisotropy
measurements for assessing the binding of eIF4GI557-1599, eIF4A, eIF4B or eIF4E to the
fluorescein-labeled RNAs were performed using the equilibrium titration module of an SF-300X
stopped-flow fluorimeter (KinTek Corporation, Austin, TX). Fluorescein-labeled RNAs were
excited at 495 nm and emission was detected using a 515 nm high-pass filter (Semrock, Rochester,
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NY). Equilibrium binding titrations began with a 200 μL sample of 10 nM of fluorescein-labeled
RNA in the Titration Buffer (20 mM HEPES-KOH, pH 7.6, 100 mM KCl, and 1 mM MgCl2) and
20-50 data points were collected for each anisotropy measurement by automated continuous
injection of 20 μL of 2.5 μM of eIF4GI557-1599, 6 μM eIF4B, 18 μM eIF4A or 12 μM eIF4E over
a period of 30 min at a temperature of 25 °C. Note that the first reading is taken in the absence of
protein. Using the Origin 2018b software package, the data were fitted to a nonlinear, equilibrium
binding equation of the form:
robs = rmin + (rmax − rmin )[

[Protein]
]
𝐾! + [Protein]

where robs is the observed anisotropy value, rmin is the minimum anisotropy value in the absence of
protein (eIF4GI557-1599, eIF4A, eIF4B or eIF4E ), rmax is the final saturated anisotropy value,
[Protein] is the concentration of eIF4GI557-1599, eIF4A, eIF4B or eIF4E and Kd is the equilibrium
dissociation constant. The chi-squared values (χ2) that represented the statistical goodness of fit
were always close to 1 and are reported in Tables 1 and 2. Fitting data to a two-site model did not
improve the fit as judged by (χ2) values. The equilibrium binding titration of each 5’ UTR was
performed three times and fit independently for Kd. The fitted Kds were then averaged and the
standard deviations were calculated (Tables 1 and 2).
3.5.4 Determinations of Number of Binding Sites
The number of binding sites (n) was calculated using the equation below;
log [(Fo − F)/F] = log KA + nlog[Q]
where, Fo and F are the fluorescence intensities of the proteins (mainly Tryptophan moiety) at
wavelength maxima with and without the presence of quencher respectively, KA is the apparent
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binding constant, n is the number of binding sites and [Q] is the concentration of the quencher
(unlabeled uncapped 5’ UTR of FGF-9 or HIF-1α).
The calculated number of binding sites “n” obtained from the above equation approximately about
unity, indicative of a single binding site interaction between the RNA and the proteins (Table
3.1and 2 and Supplementary Figures 5 and 6).

3.5.5 Preparation of UTR-Luc reporter mRNAs for luciferase-based gene expression
reporter assays
The UTR-Luc mRNA constructs for the luciferase gene expression reporter assays were generated
from the BlucB plasmid (104), which contains a firefly luciferase gene flanked by 5’- and 3’ UTR
sequences of the Barley Yellow Dwarf Virus (BYDV) genomic RNA. To generate each UTR-Luc
mRNA reporter construct, a sequence containing the T7 promoter followed by the target 5’ UTR
was cloned into the BlucB plasmid vector upstream of the firefly luciferase coding region, after
removing the BYDV 5’ UTR as follows. Briefly, all UTR-Luc reporter constructs were PCR
amplified with the forward primers containing a NotI site and reverse primers containing a BssHII
shown in Table 3.2 and then digested with NotI and BssHII. All the restriction enzymes were
purchased from New England Biolabs (NEB) and restriction digests were performed according to
the manufacturer’s instructions. The PCR-amplified sequences were ligated into a NotI- and
BssHII-digested BlucB plasmid using DNA ligase (NEB) and transformed into E. coli DH5-α
competent cells. Five colonies were selected, grown overnight in Luria-Bertani (LB) growth media
supplemented with 100 μg/mL ampicillin, and used to isolate plasmid DNA using the QIAprep®
Spin Miniprep kit from Qiagen and following the manufacturer’s protocol. To generate a linearized
plasmid DNA template for in vitro transcription, plasmid DNAs were linearized using KpnI so as
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to remove the 3’ UTR from the UTR-Luc mRNA reporter construct. The resulting linearized DNA
was purified using the GeneJET gel extraction and DNA cleanup Micro Kit from GeneJET as per
the manufacturer’s instructions. DNA templates were in vitro transcribed using T7 RiboMax Large
Scale RNA Production Kit (Promega) following the manufacturer’s protocol. ApppG (NEB) or
Ribo m7GpppA Cap Analog (Promega) were added to the transcription mix in an ApppG: GTP
ratio of 10:1 to get mRNA transcripts with non-functional caps, respectively. Capped RNAs were
polyA tailed (pA) using the Poly(A) Tailing Kit (Invitrogen) following the manufacturer’s protocol.
The resulting capped and polyadenylated mRNAs were then purified using RNA Clean and
Concentrator (RCC) Kit (Zymo) following the manufacturer’s protocol. RNA concentrations were
determined using nano-drop UV/Vis spectrometer and integrity was verified by 1.0% agarose gel
electrophoresis.
3.5.6 Luciferase-based gene expression reporter assays
Gene expression was achieved by translating the UTR-Luc mRNAs in vitro, using the nuclease
treated RRL in vitro translation system from Promega. Each 25 μL reaction contained 70% v/v of
RRL (Promega) supplemented with 0.5 mM MgCl2, 0.02 mM amino acid mixture, 10 U/μL
RiboLock RNase Inhibitor (Thermoscientific), and varying concentrations of purified eIF4A
protein as indicated in the figure legends. Rocaglamide (2 mM Stock in DMSO)
(MedChemExpress, catalog number HY-19356) and 4EGI-1 chemical (10mM Stock in DMSO)
(Selleck Chemicals, catalog number S7369) were added to the translation mix at a concentration
indicated in the figure legend (Figure 3.5). Briefly, 1 μg of UTR-Luc mRNA was added to the
RRL, in vitro translation mixture following the addition of the specified concentration of eIF4A,
Rocaglamide and 4EGI-1 chemical. The resulting in vitro translation reaction was then incubated
at 30 °C for 1 hr and stopped by the addition of 60 μM puromycin. Firefly luciferase activities
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were then assayed using SpectraMax iD5 Multi-Mode Microplate reader (Molecular Devices). To
achieve this, 3 μL of translation reaction was added to 30 μL Bright-Glo Luciferase assay reagent
(Promega) and the resulting luminescence was measured in the illuminometer over a spectral
wavelength of 350–650 nm and an integration time of 10 s at room temperature. After subtracting
the background, measured using an in vitro translation reaction to which no UTR-Luc mRNA had
been added, the luminescence data were analyzed and plotted using the Prism 8 software package.
At least 3 different batches of RRLs were used. The translation data for each UTR-Luc mRNA
were reported as an average of three independent experiments. Each independent experiment was
done in triplicate and the mean ± SD were calculated using GraphPad Prism 8. Statistical
significance between the mean values were analyzed using two-tailed unpaired student’s t-test
(GraphPad Prism 8 software). The statistical significance was set at p < 0.05 and the p-values were
calculated. The calculated p values for of the analyses are indicated as follows on the brackets
above the bar graphs (Figs. 3.5, and 3.6: n.s(non-significant), p=0.12; * , p =0.033 ; **, p =0.002;
***, p < 0.001.

3.5.7 Data availability
All data are present in the manuscript
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Table 3.1. Parameters describing the equilibrium binding of proteins to the 5’ UTR of FGF-9
RNA-eIFs

Kd ± S.D.
(nM)

Number of
binding sites
(n)

Amp.
(rmax–rmin)

eIF4GI557-1599
eIF4A
eIF4B
eIF4E
eIF4GI+4E
eIF4GI+4A
eIF4GI+4A+4E
eIF4GI+4A+4B
eIF4G+4A+4B+ATP
eIF4G+4A+4B+AMPPNP

14 ± 3
667 ± 52
38 ± 8
n/a
16 ± 3
16 ± 4
33 ± 6
24 ± 5
19 ± 3
20 ± 5

0.97 ± 0.03
0.76 ± 0.03
0.93 ± 0.01
n/a
n/a
n/a
n/a
n/a
n/a
n/a

0.137
0.010
0.144
n/a
0.089
0.047
0.075
0.065
0.036
0.032

Goodness of
fit
(χ2)
0.999
0.997
0.999
n/a
0.995
0.989
0.969
0.991
0.994
0.994

Table 3.2. Parameters describing the equilibrium binding of proteins to the 5’ UTR of HIF-1α
RNA-eIFs

Kd ± S.D.
(nM)

Number of
binding sites
(n)

Amp.
(rmax–rmin)

eIF4GI557-1599
eIF4A
eIF4B
eIF4E
eIF4GI+4E
eIF4GI+4A
eIF4GI+4A+4E
eIF4GI+4A+4B
eIF4GI+4A+4B+ATP
eIF4GI+4A+4B+AMPPNP

50 ± 6
252 ± 20
54 ± 6
n/a
15± 3
17± 2
26 ± 4
12 ± 3
17 ± 3
14 ± 3

0.91± 0.01
0.75 ± 0.02
0.74 ± 0.01
n/a
n/a
n/a
n/a
n/a
n/a
n/a

0.020
0.010
0.022
n/a
0.070
0.032
0.047
0.021
0.030
0.024
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Goodness of
fit
(χ2)
0.998
0.991
0.998
n/a
0.999
0.998
0.981
0.991
0.995
0.995

Figures and Legends

Figure 3.1. Equilibrium binding-titrations of 5’ UTRs with eIF4GI557-1599, eIF4B, eIF4E and
eIF4A. Normalized anisotropy changes for the interaction of fluorescein-labeled A.FGF-9 and B.
HIF-1α uncapped 5’ UTRs, with eIF4GI557-1599 (-g-), eIF4B (-▼-), eIF4A (- -) and eIF4E (-●-).
Briefly, 10 nM of fluorescein-labeled uncapped RNA oligos were titrated with increasing
concentrations of eIF4GI557-1599, eIF4B, eIF4E and eIF4A in the titration buffer at 25 °C and the
anisotropy at each titration point was measured using excitation and emission wavelengths of 495
nm and 520 nm, respectively. Data points correspond to the average of three independent
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anisotropy measurements and the curves represent the non-linear fits that were used to obtain the
averages and standard deviations for the corresponding Kd values presented in Figure 3.1 C and D
as well as Table 3.1.
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Figure 3.2. Equilibrium binding-titrations of 5’ UTRs of FGF-9 and HIF-1α with saturating
amount of eIF4A and eIF4GI557-1599. Normalized anisotropy changes for the interaction of
fluorescein-labeled A. FGF-9 and B. HIF-1α uncapped 5’ UTRs, with eIF4GI557-1599 (-g-), and
eIF4GI+4A (-●-). Briefly, 10 nM of fluorescein-labeled uncapped RNA oligos were titrated with
increasing concentrations of eIF4GI557-1599 alone (-g-) or eIF4GI+4A (-●-) in the titration buffer at
25 °C and the anisotropy at each titration point was measured using excitation and emission
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wavelengths of 495 nm and 520 nm, respectively. Data points correspond to the average of three
independent anisotropy measurements and the curves represent the non-linear fits that were used
to obtain the averages and standard deviations for the corresponding Kd values presented in Figure
3.2 C and D as well as Tables 1 and 2.

Figure 3.3. Equilibrium binding titrations of fluorescein labeled FGF-9 and HIF-1α binding to
eIF4GI557-1599 and a saturating amount of eIF4E and eIF4GI557-1599. Briefly, 10 nM of fluorescein86

labeled uncapped A. FGF-9 and B. HIF-1α were titrated with increasing concentrations of
eIF4GI557-1599 (-●-) only or and eIF4GI and eIF4E mixture, eIF4GI+4E (-●-) eIF4GI557-1599, in the
titration buffer at 25 °C and the anisotropy at each titration point was measured using excitation
and emission wavelengths of 495 nm and 520 nm, respectively. Average of 3 independent
experiments were performed and the curves represent the non-linear fits that were used to obtain
the averages and standard deviations for the corresponding Kds values given in Figure 3.3 C and D
as well as Tables 1 and 2
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Figure 3.4. Equilibrium binding titrations of fluorescein labeled FGF-9 and HIF-1α binding to the
helicase complex. Briefly, 10 nM of the fluorescein labelled A. FGF-9 and B. HIF-1α were preincubated with eIF4A (1 μM) and eIF4B (300 nM) (-g-) or eIF4A (1 μM) and eIF4B (300 nM)
and ATP (1 mM ATP) (- -) or eIF4A (1 μM) and eIF4B (300 nM) and AMPPNP (1 mM AMPPNP)
(-●-) at 25°C for 30 min, and then titrated with eIF4GI557-1599 in the titration buffer at 25 °C and
the anisotropy at each titration point was measured using excitation and emission wavelengths of
88

495 nm and 520 nm, respectively. Average of 3 independent experiments were performed and the
curves represent the non-linear fits that were used to obtain the averages and standard deviations
for the corresponding Kds values given in Figure 3.4 C and D as well as Tables 1 and 2.
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Figure 3.5. Rocaglamide and 4EGI-1 differentially affect the cap-independent activities of FGF9-UTR-Luc and HIF-1α-UTR-Luc reporters. A. Cartoon representation of the mRNA reporter
used for this study. Translation yields of B. FGF-9-UTR-Luc mRNA and C. HIF-1α-UTR-mRNA
were monitored in nuclease-treated RRL supplemented with DMSO (control) or increasing
concentrations of Rocaglamide. Translation yields of D. FGF-9-UTR-Luc mRNA and E. HIF-1αUTR-Luc mRNA were monitored in nuclease-treated RRL supplemented with DMSO (control) or
increasing concentrations of 4EGI-1. Bar heights and error bars correspond to the average and
standard deviations, respectively, of three independent luciferase activity measurements with
control (DMSO) set at 100%. Data were analyzed by two-tailed unpaired Student’s t-test: n.s, p <
0.033; **, p =0.002; ***, p < 0.001.
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Figure 3.6 Effect of eIF4A and eIF4E on the cap-independent activities of FGF-9 and HIF-1αUTR-Luc reporters. Translation yields of A. ApppG-capped-FGF-9-UTR-Luc mRNA and B.
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ApppG-capped- HIF-1α-UTR-Luc mRNA following treatment of the RRL with 60 nM of
Rocaglamide (RRL(+)RocA) and increasing concentration of eIF4A. C. Translation yields of ApppGcapped-HIF-1α-UTR-Luc mRNA following treatment of the RRL with 60 µM 4EGI-1 molecule
(RRL(+)4EGI-1) and increasing concentration of eIF4E. Bar heights and error bars correspond to the
average and standard deviations, respectively, of three independent luciferase activity
measurements with control (DMSO) set at 100%. Data were analyzed by two-tailed unpaired
Student’s t-test: n.s, p =0.12; *, p < 0.033; **, p =0.002; ***, p < 0.001.

Figure 3.7. Cartoon summarizing models of cap-independent translation switch under stress
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condition. In the top panel, active mTOR (mammalian target of rapamycin) hyper phosphorylate
4EBP1, making its inactive and facilitating recruitment of the cap-binding protein, eIF4E, to the
m7G-capped mRNA, and with the aid of other eIFs and 43 S PIC, initiate canonical cap-dependent
translation. In the bottom panel, inactive mTOR leads to hypo phosphorylation of 4EBP1 which
binds eIF4E and competitively displace eIF4GI from interacting with eIF4E. Under this condition,
our model shows eIF4GI binds to eIF4A and eIF4E resulting in conformational change in eIF4GI
that binds with higher affinity to structured 5’ UTR to recruit the 43S PIC to promote a CITE-like
mechanism whereas for IRES-like mechanism, eIF4GI alone is sufficient to stably bind to
structural elements within the 5’ UTR, but eIF4A is still required for efficient translation.
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Supplementary Data

Figure S1. Equilibrium binding-titrations of unstructured polyUC with eIF4GI557-1599(-g-), eIF4B
(-▼-), eIF4E (-●-) and eIF4A (- -). Briefly, 10 nM of fluorescein-labeled uncapped polyUC RNA
oligos wAS titrated with increasing concentrations of eIF4GI557-1599, eIF4B, eIF4E and eIF4A in
the titration buffer at 25 °C and the anisotropy at each titration point was measured using excitation
and emission wavelengths of 495 nm and 520 nm, respectively. Data points correspond to the
average of three independent anisotropy measurements.
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Figure S2. Equilibrium binding-titrations of flourecein labelled 5’ UTR of A. FGF-9 (-●-) and
B. HIF-1α (-●-) with eIF4GI557-1599 eIF4E and eIF4A mixture (eIF4GI+4A+4E). Briefly, 10 nM of
fluorescein-labeled uncapped FGF-9 or HIF-1α oligos was titrated with increasing concentrations
of eIF4GI+4A+4E in the titration buffer at 25 °C and the anisotropy at each titration point was
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measured using excitation and emission wavelengths of 495 nm and 520 nm, respectively. Data
points correspond to the average of three independent anisotropy measurements.

Figure S3. Predicted secondary structures for A. HIF-1α and B. FGF-9 using RNA2Drawer (120).
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557 eIF4E RNA eIF4A/eIF3/RNA

eIF4A

MnK1 1599

Figure S4. Domain architecture of eIF4GI557-1599 used for this study. A. Cartoons showing the
domain architecture of eIF4GI557-1599 showing the domains B. A 10% SDS-PAGE gel showing
purity of eIF4GI557-1599, eIF4A, eIF4B and eIF4E used for this study.
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Figure S5. Modified Stern−Volmer plots showing the fluorescence quenching of 25 nM A.
eIF4GI557-1599, B. eIF4B, and C. eIF4A by 1μM of FGF-9 over a period of 30 min at a temperature
of 25 °C.
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Figure S6. Modified Stern−Volmer plots showing the fluorescence quenching of 25 nM A.
eIF4GI557-1599, B. eIF4B, and C. eIF4A by 1μM of HIF-1α over a period of 30 min at a temperature
of 25 °C.
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CHAPTER 4
4.1 Conclusion and Future directions
4.2 Conclusion
In conclusion, the research presented in this dissertation was focused on the elucidation of
how a subset of physiologically important mRNAs with structured 5’ UTR mediate a switch from
canonical cap-dependent translation to cap-independent translation initiation under stressful
conditions. Cap-independent translation initiation has been extensively studied in viral mRNA
system but there are only few studies on cellular mRNAs. Such studies have speculated the role of
eIF4GI and DAP5 in cap-independent translation of cellular mRNAs but with no direct evidence
reported yet. Further, DAP5 and eIF4GI are proteins that have been shown to be elevated during
various stress conditions and the altered levels of these proteins corresponded with increased
translation of stress response mRNAs. Since eIF4E is sequestered by 4E-BP1 during these stress
conditions, these mRNAs must utilize alternate cap-independent translation mechanisms for
protein translation. In this dissertation, we aimed to bridge this gap in our knowledge by
investigating how these stress response mRNAs namely HIF-1α, FGF-9, p53A and p53B recruit
eIF4GI or DAP5 to their structured 5’ UTRs. We hypothesized that, eIF4GI or DAP5 are directly
recruited to the 5’ UTRs of these stress response mRNAs to mediate a switch from a cap-dependent
to a cap-independent translation initiation mechanism.
This study is the first to report quantitative binding of cellular RNAs to key translation
initiation factors and demonstrated direct interaction between eIF4GI/DAP5 and the 5’ UTRs of
HIF-1α, FGF-9 and p53, which can partly explain the basis of their cap-independent translation.
Using fluorescence anisotropy-based equilibrium binding assay to measure the binding affinities
of these mRNAs to the proteins, we showed that two variants of the eIF4GI construct; the
102

eIF4GI557-1599 containing the eIF4E binding domain and eIF4GI682-1599 without the eIF4E binding
domain, and full length DAP5 protein bind specifically and with high affinity to the uncapped 5’
UTRs of HIF-1α, FGF-9, p53A and p53B. The higher binding affinity of eIF4GI557-1599 to the
selected 5’ UTRs compared to eIF4GI682-1599 suggests that the specificity of the binding reside in
the eIF4E binding domain. Further, using a nuclease-treated rabbit reticulocyte lysate (RRL), and
a firefly luciferase reporter expression system for the mRNAs, we showed how their capindependent translation activity is dependent on the availability of eIF4GI or DAP5 in the lysate.
We demonstrated that in a nuclease treated-RRL where eIF4GI or DAP5 has been depleted, adding
back purified eIF4GI constructs or DAP5 significantly rescued the cap-independent translation
activity of all reporters containing the selected 5’ UTRs (HIF-1α, FGF-9, p53A and p53B) but not
the reporter containing beta-actin 5’ UTR suggesting that the stimulation by the proteins were
specific. Previous reports have suggested the requirement of a free 5’end for CITE containing
mRNAs, whereas IRES could recruit ribosomes internally without the need for a free 5’end (15).
Using an extension of the firefly reporter system where a stable hairpin was inserted at the 5’ end
of the reporters, allowed us to distinguish amongst the subsets of mRNAs that are translated using
either a CITE-like or an IRES-like mechanism. Also, the factor requirement differs among various
mRNAs utilizing CITE and IRES like mechanisms, with IRESs requiring none to a very few
factors to effectively recruit the PIC (1,16). To further understand the initiation factor requirements
for efficient translation of these mRNAs, we investigated what additional initiation factors may be
important for this mechanism. Our previous report (111) suggested that HIF-1α 5’ UTR functions
mainly as a CITE with requirement for a free 5’ end whilst FGF-9 functions more like an IRES.
We show that the initiation factor requirements by these two 5’ UTRs is distinct, further confirming
different cap-independent translation mechanisms. Specifically, we showed that additional factors
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eIF4A and eIF4E enhanced the binding affinity of eIF4GI557-1599 to the 5’ UTR of HIF-1α but not
FGF-9. However, the observation that eIF4A inhibitor (Rocaglamide) impacted the translation
efficiencies of both reporters containing the 5’ UTRs of HIF-1α and FGF-9 suggest that mRNA
structure remodeling could be a common feature by which these mRNAs recruits 43 S PIC to
initiate a CITE-like or IRES-like cap-independent translation initiation. Additionally, eIF4A has
been reported to perform crucial helicase-independent roles in PIC recruitment and translational
regulation by modulating the conformation of the 40S ribosomal subunits (117,118), and addition
of the inhibitor could affect these roles.
Taken together, this dissertation uncovered the important roles of mRNA structures within
the 5’ UTR of subset of human mRNAs, how these mRNAs directly recruits key initiation factors
and provide a plausible mechanistic insight as to how these mRNAs could mediate a capindependent translation initiation using either a CITE or IRES elements. Further studies
investigating how other initiation factors facilitate recruitment of DAP5 to the 5’ UTRs is currently
in progress and discussed further in the next section of this chapter.
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4.3 Future Direction
The observation that eIF4GI and DAP5 interacted specifically with the 5’ UTRs of HIF1α, FGF-9, p53A and p53B but not an unstructured polyUC nor a natural 5’ UTR of β-actin suggest
that these proteins may recognize unique structural features in the various 5’ UTRs to which they
bind. Analysis of the predicted secondary structures of our 5’ UTRs using RNAalifold software
modelling program showed that there is a putative Y-shape motif common to selected 5’UTRs
(Fig. 4.1 and 4.2) that could serve as likely recognition elements and binding sites for eIF4GI
constructs or DAP5. This consensus structure share a striking resemblance to the EMCV J/K IRES
(Fig. 4.2 ) as well as other picornaviruses IRESs, plant viruses such as Kl-TSS and cellular
mRNAs such as BiP, Antp and FGF-2 (121,122). Sequence comparison of the putative Y-shaped
stem loop among the 5’-UTRs and the EMCV J/K IRES did not reveal any notable sequence
similarity (Fig. 4.2) suggesting that these proteins may recognize and bind to structured features
within the 5’ UTR. Apart from p53A and p53B whose structure have been determined (79), the
structure of HIF-1α and FGF-9 remained to be experimentally validated. Further, determination of
the binding sites/regions on the 5’ UTRs to which the proteins bind will validate the hypothesis
that these proteins recognize and bind to specific structural elements within the 5’ UTRs of our
selected mRNAs. These structural studies will provide further insights into the specificity of these
interaction.
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Figure 4.1 Predicted Y-shape motif common among the 5’ UTR of HIF-1α, FGF-9 , p53A and
p53B using RNAalifold software. Bottom panel represent the colored nucleotides that correspond
to the Y-shaped stem loop sequences found within predicted secondary structures for HIF-1α,
FGF-9 , p53A and p53B.
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Figure 4.2 Predicted secondary structures and alignments for A. HIF-1α B. FGF-9 C. p53A D.
p53B E. EMCV J/K domain IRES and F. β-actin by RNA2Drawer (120). The colored nucleotides
correspond to the Y-shaped stem loop sequences found within predicted secondary structures. G.
Predicted Y-stem loop sequence alignments by Clustal Omega for EMCV J/K domain IRES, FGF9, p53B, HIF-1α and p53A.
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Determination of the other initiation factors that facilitate recruitment of DAP5 to the 5’
UTRs of these subset of mRNA will shed more light on these mechanisms of cap-independent
translation initiation mediated by DAP5. A few initiation factors that has been proposed to interact
with DAP5 include eIF4A, eIF3d and eIF2β (33,65). The initiation factors eIF4A, and eIF2β are
direct interaction partners for DAP5(33) whilst eIF3d mediate recruitment of DAP5 to facilitate a
novel form of cap-dependent translation that involve eIF3d recognition of the m7G cap instead of
eIF4E (65). Understanding how these other initiation factors interact with DAP5 to stabilize its
interaction with the 5’ UTRs will provide further mechanistic insight into how these mRNAs are
translated.
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